Age-associated memory impairment: diagnostic and treatment issues by Barker, Andrew
        
University of Bath
DOCTOR OF MEDICINE








Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 14. May. 2019
DEDICATION
To Pam, Lucy and Adam for helping me to find my truth, and to Mum 
and Dad for teaching me to appreciate the beauty of stars.
Where is man's truth to be found?
Truth is not that which can be demonstrated by the air of logic. If in this 
bit of ground, and not in another, orange-trees grow sturdy and are rich 
in fruit, then this bit of ground is truth for orange-trees.
If a particular religion, or culture, or scale of values, if one form of 
activity rather than another brings self-fulfillment to a man and releases 
the prince within, then this scale of values, this culture, this form of 
activity constitutes his truth.
Antoine de Saint-Exupery, from "Terre des hommes" (1939).
We are all in the gutter, but some of us are looking at the stars.
Oscar Wilde, from "Lady Windermere's Fan" (1891).
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STAI-S State-Trait Anxiety Inventory - State
STAI-T State-Trait Anxiety Inventory - Trait
VOCABIQ IQ estimated from the Vocabulary subtest of the WAIS
WAIS Wechsler Adult Intelligence Scale
WAIS-R Wechsler Adult Intelligence Scale (revised)
WAIS Vocab Vocabulary subtest of the WAIS 
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Memory Scale 
WALT (hard) Hard score on the WALT
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ABSTRACT
Reports of deteriorating memory are common with increasing age. In a 
minority of cases these may be the recognition of the first signs of 
dementia. In most people however, they relate to non-disease ageing- 
related changes in cognition.
The term Age-Associated Memory Impairment (AAMI) was proposed, 
with diagnostic criteria, by a Work Group of the United States National 
Institute of Mental Health to describe people suffering from an ageing- 
related decline in memory (Crook et a/, 1986). No prevalence study has 
yet been performed with the full set of diagnostic criteria and little work 
has been carried out to assess the validity of these. Despite these 
criticisms, pharmacological treatment trials have already been reported, 
and AAMI is likely to appear in some form in DSM-IV, the forthcoming 
updated version of DSM lll-R (American Psychiatric Association, 19 87 ), 
an internationally used classification of mental disorders.
In this thesis a prevalence study of AAMI is described. Prevalence rates 
are reported, but these vary dramatically with minor alterations to the 
diagnostic criteria. Several individual criteria are critically examined and 
suggestions for improvements are made.
Three further studies are described which investigated factors involved in 
the presentation of memory complaint to a self-referral memory clinic by 
people with mild cognitive impairment. Memory complaint in particular
v
was chosen for additional investigation because it is with this symptom 
that people with AAMI will present to doctors, and also because a poor 
correlation had been shown between memory complaint and test 
performance in the prevalence study, despite this symptom being an 
essential part of diagnosis in AAMI.
Memory complaint in attenders at a self-referral memory clinic appears to 
be more closely related to affective and personality factors than memory 
performance. Controversial issues regarding the concept and treatment 
of AAMI are discussed.
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FOREWORD
The purpose of this thesis is to examine the concept, diagnostic criteria 
and prevalence of Age-Associated Memory Impairment (AAMI), a term 
proposed by a Work Group of the United States National Institute of 
Mental Health to describe people suffering from an ageing-related decline 
in memory (Crook et al, 1986). The concept of AAMI is based on the 
premise that such ageing-related changes exist, and that they are the 
psychological manifestations of underlying neurobiological changes in the 
central nervous system.
Chapter 1 is a general introduction to the area. Current psychological 
models of memory are presented and methodological problems of ageing- 
related research are examined. The evidence for ageing-related changes 
in memory and neurobiology is reviewed, and the significance of such 
changes discussed. A section on Benign Senescent Forgetfulness (BSF) 
is included since this term is already commonly used to describe elderly 
people with ageing-related changes in memory, and is the description 
that AAMI aimed to improve upon. The final section introduces the 
concept and diagnostic criteria of AAMI.
Chapter 2 describes the main project of the thesis; a prevalence study of 
AAMI with examination of some of the more important of the diagnostic 
criteria proposed.
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Many argue for the future pharmacological treatment of AAMI. The self­
referral memory clinic at the Research Institute for the Care of the Elderly 
(RICE) attracts many older people requesting medical help because of 
memory dysfunction. It is therefore an ideal setting to examine factors 
involved in self-presentation of memory complaint.
Chapter 3 describes characteristics of the first 100 people who attended 
the self-referral memory clinic. Chapters 4  and 5 describe two studies 
which examine the significance of memory complaint in people 
presenting to the self-referral memory clinic.
The final chapter is a general discussion of the findings and conclusions 
of the research performed for this thesis. Controversial issues regarding 




Age-Associated Memory Impairment, the subject of this thesis, refers to 
an ageing-related change in secondary memory. The reader may not be 
familiar with terms used in psychological models of normal memory 
functioning, so the first section of this chapter aims to give a brief 
introduction to the area.
Methodological problems of research into ageing-related phenomena will 
be examined before describing the evidence for changes in memory and 
neurobiology with ageing, since these will limit the conclusions which 
can be drawn from such evidence. The chapter concludes with sections 
on BSF and AAMI.
1.1 Normal memory functioning
The term memory describes the registration, retention and retrieval of 
information. It is one of a number of cognitive functions carried out in 
the brain which include language, praxis, visuospatial and perceptual 
function and conceptualization (Rabins, 1992).
1.1.1 THE MULTISTORE MODEL OF MEMORY
The multistore model of memory was proposed in its original form by 
Broadbent (1958), some thiry five years ago. He described a model 
where memory functioning was divided into three discrete parts: a
3
sensory store, a short term store and a long term store. Other 
researchers have subsequently produced amended and amplified 
versions, but the basic structure remains the same.
Sensory memory is that which enables us to make use of stimuli entering 
our nervous system. It allows the holding of information at a 
subconscious level long enough to be able to recognise patterns and 
select the relevant or important information that needs to be transferred 
into short term memory (Greene and Hicks, 1984; Duchek, 1991).
Short term memory is used for cognitive task processing such as 
remembering the first half of a sentence while reading the second half, 
remembering a phone number in order to dial or for mental calculation. It 
has also been called "primary", "immediate", or "working" memory (see 
Baddeley below).
Long term memory is for more permanent storage of memory that will be 
needed for future retrieval. It is also known as "secondary" memory, 
although some researchers refer to secondary memory as "recent" 
memory and add "tertiary" memory to refer to remote, distant, memory 
(Crook et a! 1986).
1.1 .2 WORKING MEMORY
Baddeley (1986) developed the concept of short term memory as 
"working memory", which concerns temporary storage used in a wide 
variety of information processing skills. It overlaps conceptually with the 
short term memory store in the multistore model of memory, but uses a 
more functional approach. Working memory in Baddeley's model
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consists of a collection of temporary storage subsystems coordinated by 
a "central executive". The two subsystems so far described are the 
visuospatial scratch pad (or sketch pad) and the articulatory loop. The 
visuospatial scratch pad is probably used for the temporary retention of 
spatial or patterned visual information. The function of the articulatory 
loop is for the temporary retention of short streams of words, for 
example in silent reading, necessary for fluent reading ability.
The central executive carries out all functions not performed by other 
subsystems, but in the main has a supervisory role in attention control. 
Baddeley thinks of the central executive as a system that cuts in when 
the routine automatic "schemata" processing of information cannot 
continue undisturbed, either because of conflicting demands, or because 
a high degree of attention is required because of risk or particular 
importance.
The central executive and the two subsystems which have so far been 
elucidated are capacity limited. Tasks that require simultaneous retrieval, 
selection and storage will therefore place the greatest demands on the 
central executive. Although Baddeley's working memory theory is set 
within the multistore model of memory, he sees these systems as 
important in a variety of other cognitive tasks which rely heavily on 
information processing.
1.1 .3 THE MEMORY TRACE
Broadbent believed that effective transfer of a memory to the long term 
store involved the laying down of a "memory trace"; a record of 
processing that has occurred. This idea was elaborated by Craik and
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Lockhart with "levels of processing" theory (see Parkin, 1987). The 
"deeper" or more elaborate and extensive the processing, the more 
durable the memory trace was felt to be. Orthographical (visual) 
processing was the most superficial, phonological (auditory) next, and 
semantic (meaning) the deepest and hence the most durable. The theory 
of levels of processing led to improved memory training based on 
elaboration and semantic coding of information, rather than pure 
rehearsal. Its popularity declined however, probably because of the lack 
of testable hypotheses generated (Parkin, 1987).
1 .1 .4  PROCEDURAL, PROPOSITIONAL, EPISODIC AND SEMANTIC 
MEMORY
Tulving (1983) developed the concept of the long term memory store, 
dividing it into procedural and propositional memory. These refer to the 
learning of skills and factual knowledge respectively. Propositional 
memory could be divided into episodic and semantic memory. Episodic 
memory refers to personally experienced events, whereas semantic refers 
to knowledge of the world that is independent of a person's identity and 
past, and generally consists of words and concepts. He differentiated 
the two types on the basis of the sorts of information processed by 
them, characteristics of their operations, and their applications in real life.
Episodic memory is experiential and is coded temporally. Retrieval of 
episodic memory makes it more likely to be remembered at a later time 
but tends to modify the memory. Semantic information is normally 
received in symbol form (usually language), and is conceptually coded. 
Semantic memories tend to be overlearned rather than single episodes of 
experience. They are usually added into a person's pre-existing
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conceptual structure, so are less likely to be changed, modified or lost. 
Retrieval of semantic memory, may make later access quicker. Tulving 
(1983) demonstrated that information that has been semantically rather 
than episodically coded is subsequently more accurately retrieved.
1.1.5 FLUID AND CRYSTALLIZED INTELLIGENCE
A further distinction that is made by many psychologists is between 
"fluid" and "crystallized" intelligence (Belsky, 1984; Rabbitt 1992). Fluid 
intelligence is the ability to devise a solution to a newly presented 
problem, and can be seen as the efficiency of rapid information 
processing. Performance IQ tests measure this construct. Crystallized 
intelligence includes the systems involved in long term retrieval from a 
person's accumulated store of factual knowledge. Verbal intelligence 
tests are often used to assess this factor for estimation of premorbid IQ 
in the elderly, since scores tend to be stable over time from adulthood 
onwards (Crawford, 1992) and in a variety of clinical conditions 
associated with old age (Crawford et al, 1988).
1.2 Methodological problems of ageing-related research in memory and 
neurobiology
Before reviewing the evidence for ageing-related changes in memory and 
neurobiology, it is important to recognise the methodological limitations 
of research attempting to measure changes across the lifespan. These 
include the cohort effect, the effects of physical and functional mental 
illness and the problems of defining, diagnosing and excluding cognitive 
illness (Rabins, 1992). It is pertinent at this point to highlight the
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difference between age-related and ageing-related changes. Many things 
change with increased age, both internally and in the external 
environment: some of these are caused by the ageing process itself and 
many others are due to factors independently associated with a person's 
chronological age. Age is a state and ageing a process.
1.2.1 THE COHORT EFFECT
Most studies examining ageing-related changes in memory and cognition 
are cross-sectional: they compare groups of young and old subjects and 
analyze psychometric data for differences between them. The 
alternative, following up large groups of people for several decades, is 
extremely demanding both practically and financially. By the time results 
are obtained, they are automatically several decades out of date. There 
are methodological problems, however, in treating cohorts of people of 
differing ages as though they are distinguished solely by their 
chronological age (Belsky, 1984). Two longitudinal studies demonstrate 
how the cohort effect can affect conclusions drawn from cross-sectional 
studies.
Schaie and Labouvie (1974) assessed randomised community subjects 
from the ages of 21 to 84 years in seven-year cohorts cross-sectionally 
and then longitudinally over 14 years. All ten cognitive measurement 
variables on cross-sectional comparison showed age-related decrements 
in function, often starting in the 20's or 30's. However, only five of 
these showed progressive changes over the follow-up period, and these 
were far smaller than predicted by the cross-sectional comparison.
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These findings were backed up by a prospective study (Arenberg, 1990) 
over 12 years of 400 men from the ages of 20 to 7 0 +  using the Benton 
Visual Retention Test (a measure of secondary memory). Test scores at 
baseline showed a progressive decline across 10 year age bands, but 
over the follow-up period only the older groups (50's and above) showed 
a deterioration in scores.
1.2.2 EXPLAINING THE COHORT EFFECT
People of different ages may have previously had, and may currently 
have, different psychological, social and physical experiences which 
might affect their performance on psychometric tests as well as their 
underlying neurobiology. Any variation seen between two differently 
aged cohorts may actually represent these differing past and current 
experiences rather than a change due to ageing itself.
It is argued (Perlmutter et al, 1987) that differences in past educational 
experience will affect the use of mnemonic techniques and test-taking 
ability as well as a person's attitude towards continuing education and 
intellectually challenging leisure activities. Perlmutter et al also drew 
attention to the role of common stereotypes of ageing on social 
conditions and internal and external expectations of an elderly person, all 
of which may directly affect memory performance.
Rabbitt (1992) demonstrated how highly practised memory skills can give 
improvements in specific areas of memory performance. Age-related 
memory differences may be affected by which particular skills have been 
gained during life and also by which skills are currently relevant to a 
person's social demands and so are practised. Some attempts have been
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made to improve the relevance, or "ecological validity" of cognitive tests 
for the elderly, for example by matching names to faces on video screens 
(Crook et at, 1990^). No standardized testing has yet been developed 
for use in the home on everyday household tasks, though the process 
abilities component of the Assessment of Motor and Process Skills 
assessment tool (Doble, 1991; Fisher, 1993) may be of value in the 
future.
Past or present lifestyle influences such as nutrition and exercise may 
also change with age and make interpretation of cross-sectional 
differences in neurobiology difficult (Prendergast and Armbrecht, 1990; 
Morris and McManus, 1991).
Finally, the older the study cohort becomes, the more and more selective 
becomes the group studied. A cross-sectional study of "normal" ageing 
from the age of 80 to 100 would include a majority of dead subjects. In 
longitudinal studies, loss of "at-risk" subjects makes the remaining group 
likely to have been supernormal at baseline rather than average.
1.2 .3 THE EFFECTS OF PHYSICAL AND MENTAL ILLNESS
Elderly people suffer from more physical and functional mental illnesses 
than young people and as a result tend to be receiving more medications. 
A variety of drugs and medical conditions are known to affect sensory, 
primary and secondary memory, and may practically interfere with test 
taking. In these circumstances it is difficult to separate the effects of 
ageing on memory from these age-associated physical factors. The 
exclusion of people with particular medical problems and medications is
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one way around this, but again at the risk of only including 
"supernormal" individuals.
There are a number of methodological problems regarding cognitive 
illness in research investigating ageing-related memory changes. These 
include the difficulty of diagnosing mild dementia and, more broadly, in 
defining dementia and distinguishing it from normality.
1 .2 .4  THE EFFECT OF DEMENTIA
Dementia is an umbrella term used to describe a syndrome of multiple 
higher cognitive deficits in which there is commonly a decline in intellect, 
personality and behaviour. It is normally chronic and progressive. The 
prevalence increases with age in an exponential fashion, approximately 
doubling in magnitude every five years from the age of 60 onwards 
(Jorm, et a! 1987; Hofman et al, 1991). It can be caused by a variety of 
brain diseases (WHO, 1992) and most commonly Alzheimer's disease 
and multi-infarct dementia (Jorm et a! 1987; Brayne and Calloway, 1989) 
although the prevalence of senile dementia of Lewy body type has 
probably been underestimated (Perry et al, 1990).
In studies of ageing-related changes in memory, people with dementia 
are usually excluded, since dementia is seen as an age-related disease 
rather than an ageing-related process. It could be argued that age- 
related differences demonstrated in cognition or neurobiology are due to 
the greater number of people with dementia with increasing age. 
Attempts are generally made to exclude these subjects, but first, a 
diagnosis has to be made.
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1.2.5 THE DIFFICULTY OF DIAGNOSING MILD DEMENTIA
Dementia, and particularly Alzheimer's disease, often has an insidious 
onset and patients are extremely difficult to identify. Some attempts 
have been made to predict decline in people with mild cognitive changes 
(Boiler et al, 1991; Burns et al, 1991; Flicker et al, 1991), but as yet 
there is no generally applicable psychological or biochemical diagnostic 
marker for Alzheimer's disease. Genetic techniques are unlikely to 
provide all the answers (Whalley, 1991). Definitive diagnosis of 
Alzheimer's disease can only currently be made by examination of brain 
tissue for histological analysis. This is normally only obtained post 
mortem or rarely by brain biopsy, so for research purposes the exclusion 
of people with Alzheimer's disease is based on clinical assessment.
Unfortunately, a variety of factors can affect cognitive performance with 
resulting misdiagnosis of mild dementia. These include low IQ and poor 
educational background, low social class, and medical and psychiatric 
factors (Henderson and Huppert, 1984; Burvill, 1993). Rosenman (1991) 
followed a group of 75 elderly people over 3 years and used progression 
of cognitive impairment to validate an initial diagnosis of mild dementia. 
He found poor agreement between five operational diagnostic methods 
for subjects who had validated mild dementia. These methods showed 
no more accurate prediction of dementia than clinical judgement alone or 
a simple 23 /24  cutoff on the Mini-Mental State Examination, a short 
screening test for dementia (Folstein et al, 1975).
Because of the uncertainty of the significance of mild memory problems, 
many different terms are in existence which describe mild memory 
impairment in the elderly not sufficiently severe to merit the diagnosis of
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dementia (Dawe et al, 1992). Widely used terms include "subcases" of 
dementia in the Geriatric Mental State (see Copeland et al, 1992), 
"Limited cognitive disturbance" in the Comprehensive Assessment and 
Referral Evaluation (CARE) (Gurland et al, 1982), "Questionable 
dementia", CDR 0.5 in the Clinical Dementia Rating scale (Hughes et al, 
1982), "Minimal dementia" in the Cambridge Mental Disorders in the 
Elderly Examination (CAMDEX) (Roth et al, 1986), "Mild Organic 
Psychosyndrome" (see Hindmarch et al, 1991), "Very mild cognitive 
decline" from the Global Deterioration Scale (GDS 2, the "phase of 
forgetfulness") (Reisberg et al, 1982), "Benign Senescent Forgetfulness" 
(Krai, 1958) and "Age-Associated Memory Impairment" (Crook et al, 
1986).
The purpose of some of these diagnostic labels is unclear, whether to 
identify people who are likely to be in the early stages of a dementing 
process, those with a non-progressive cognitive impairment, those with 
ageing-related changes or a group of people not otherwise classifiable in 
prevalence studies of cognitive impairment. Follow-up studies are not 
always available. Dawe et al (1992) reviewing some of the studies in 
which these terms had been used, reported an annual incidence of 
dementia varying between 1 and 25% . O'Brien and Levy (1993) note 
that longitudinal studies on categories of mild memory impairment 
generally show little progression to dementia when primarily based on 
subjective memory complaint, but more when based on objective deficits.
In order to improve the clinical diagnosis of Alzheimer's disease, 
operational criteria have been produced (McKhann et al, 1984; American 
Psychiatric Association, 1987) which improve diagnostic reliability of
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established disease (Tierney et al, 1988). Similar criteria have also been 
proposed for diagnosing multi-infarct dementia (Roman et al, 1993).
Diagnosis is further complicated by disagreements over classification, 
even for Alzheimer's disease. Some propose that young onset disease 
should be distinguished from that of later onset, and base the distinction 
on neurochemical, pathological and genetic evidence (Gottfries, 1985). 
Certainly, the genetic factors that look convincing in early onset disease 
appear different from later onset cases (Harrison, 1993; Poirier et al, 
1993; Scott, 1993), and the distinction between ageing related changes 
and dementia is harder in the elderly where many interacting causes of 
cognitive impairment coexist (Wilcock, 1988; Barker, 1992; Murphy, 
1992). This area is particularly challenging for diagnosis, and there is a 
lack of widely accepted diagnostic criteria for mild dementia.
1 .2 .6  THE DIFFICULTY OF DEFINING MILD DEMENTIA
Henderson and Huppert (1984) found estimates of the prevalence of mild 
dementia in elderly populations varying between 2.6%  and 52.7%  
because of different methods of identifying subjects and diagnostic 
criteria used. Mowray and Burvill (1988) applied a variety of diagnostic 
criteria from different schedules for mild dementia in a single community 
population of over 70 year olds, and found prevalence rates varying 
between 3%  and 64% . Problems experienced in applying diagnostic 
criteria included the interpretation of what constituted "significant" 
interference with work, social activities or relationships, and also the 
differentiation of cognitive from physical factors in limiting function.
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Diagnosing and excluding people with mild dementia from studies 
examining ageing-related changes is therefore problematical. However, a 
new layer of complexity is added when the existence of dementia as 
distinct from normality is questioned. If normal ageing and dementia 
were part of a continuum, as has been suggested (Brayne and Calloway, 
1988), then any attempt to describe "normal" ageing-related changes 
would be meaningless.
1 .2 .7 THE DIFFICULTY OF DISTINGUISHING DEMENTIA FROM 
NORMALITY AND THE CONTINUUM APPROACH
Brayne and Calloway (1988) studied the frequency distribution of scores 
on a modified Blessed dementia scale and the information memory 
concentration scale in an elderly population, since both are correlated 
with the cholinergic deficit and with the numbers of brain plaques and 
tangles seen in patients with Alzheimer's disease (Blessed et al, 1968; 
Perry et al, 1978). They showed that in an elderly community population 
the frequency distributions of these scales are highly skewed, smooth 
and unimodal, suggesting that normality and senile dementia of the 
Alzheimer's type lie on a continuum, cutoff points being arbitrary.
The paper was criticized (Hofman et al, 1988) because of the crude 
nature of the measuring instruments and the heterogeneity of the 
population studied. The comparison was drawn with atherosclerotic 
changes which increase in prevalence with age and are distributed 
unimodally, but would not be considered by most to be part of normal 
ageing because of their association with myocardial and cerebrovascular 
disease.
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There is disagreement over what the continuum view represents. Dawe 
et aI (1992) use continuum to mean that it is very difficult to distinguish 
between early dementia and normal ageing. This is unhelpful as it adds 
nothing to the clarification of factors associated with progression of 
cognitive impairment. Accepting the continuum view prematurely carries 
the danger that there might be less research directed at more accurate 
methods of predicting prognosis, or discovering subtypes of disease for 
future treatments. Conversely, accepting the binary view too readily 
might limit study design and hence the conclusions that could be drawn 
from research findings. The issue may not be resolved until longitudinal 
studies are performed which include neuropathological and psychometric 
assessment on a randomised community population with a full range of 
cognitive function (Brayne, 1993).
Although Brayne and Calloway's position has supporters (Crook et al, 
1986; Anon (Editorial), 1989), the consensus at the present time 
amongst researchers is that Alzheimer's disease and normal ageing are 
distinct because of a variety of quantitative and qualitative 
neuropathological (Katzman, 1988; Wilcock, 1988; Muller et al, 1991), 
neurochemical (Bowen et at, 1979; Bartus et al, 1982) and psychological 
(Huppert and Kopelman, 1989) differences.
1.3 Subjective reports of memory changes with ageing
Reports of deteriorating memory are common with increasing age. In a 
large study of volunteers aged 50 to 79 all subjects felt their memory had 
declined in the previous thirty years (Abson and Rabbitt, 1988). Memory 
complaints are very common in general population samples also (Bowles
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et al, 1989), older people reporting more retrieval failures than the 
young.
However, there are problems with taking these self reports as evidence 
of true decline in memory, since a number of studies have shown there is 
little relationship between memory complaint and objective memory 
performance (Popkin et al, 1982; Abson and Rabbitt, 1988; O'Connor et 
al, 1990).
Memory complaint is probably more closely related to depression ratings 
than objective test performance in both depressed and normal community 
dwelling adults (Popkin et al, 1982; Bolla et al, 1991). Elderly people 
expect their memory capacity to deteriorate and tend to be more upset 
by memory problems than the young (Perlmutter et al, 1987). Therefore 
more objective evidence is required to prove the existence of true ageing- 
related changes in memory.
1.4 Objective measures of memory changes with ageing
Reviews of ageing-related memory performance generally agree that 
sensory memory, primary (short term) memory, and tertiary (remote) 
memory decline little with age, but that tests of secondary (recent) 
memory show marked differences between young and old subjects (Craik 
1977; Poon, 1985; Crook et al, 1986; Cunningham and Brookbank, 
1988; Rabbitt, 1992). In particular, the retrieval process in secondary 
memory appears to be affected (Bowles et al, 1989). These changes are 
present even after cohort effects are taken into consideration (Schaie and 
Labouvie, 1974; Arenberg, 1990).
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A variety of memory tests have been used in ageing-related research, 
often concentrating on a particular area or domain of secondary memory. 
However, performance on different domain-specific tests varies both 
within and between individuals. This can be so for a variety of reasons: 
people have natural strengths and weaknesses, some practise particular 
skills more than others and some people have a higher general ability 
than others in terms of performance IQ/fluid intelligence. It is not 
surprising therefore, that age is more closely correlated with a measure 
of performance IQ such as the AH4 test (Heim, 1970) which assesses a 
variety of information processing skills, than it is with individual tests 
(Abson and Rabbitt, 1988). Current memory functioning is also more 
closely correlated with performance IQ than with age (Winthorpe and 
Rabbitt, 1988). After controlling for AH4 score, little age-related change 
exists in individual test scores (Rabbitt, 1988; Cockburn and Smith, 
1991). Therefore, although memory declines with age, performance IQ 
does also, and after the age-related change in IQ is taken into account, 
little residual variance in individual test performance remains.
1.4.1 SLOWED INFORMATION PROCESSING AS THE MEDIATING 
FACTOR IN AGEING-RELATED MEMORY DECLINE
The reduced performance IQ associated with ageing appears to be 
related to a slower information processing rate (Stine et al, 1989). 
Slower information processing predicts less "deep" processing and also 
allows less rehearsal in working memory, functionally reducing working 
memory capacity. Light and Burke, pre-eminent in this field, believe that 
age-related changes in both language and memory are due to a decrease 
in working memory capacity (Light and Burke, 1988).
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Slowed information processing is also identified by Rabbitt as the most 
sensitive index of general cognitive change in old age (Rabbitt, 1992). 
This would suggest that not just memory, but all cognitive systems may 
be affected to some extent by ageing, and indeed Baddeley (1986) 
showed that a number of non-memory tasks that rely on the central 
executive are worse in the elderly, such as reaction time, visual search 
and comprehension. Thus ageing-related changes in cognition will affect 
a wide range of everyday skills (Crook et at, 1986; Rabins, 1992).
Since working memory is a primary memory function, one may ask why 
no reliable changes in primary memory are found with increasing age. 
Most research of primary memory has used simple tests, for example the 
digit span. Baddeley's working memory model predicts that age-related 
differences would be more evident when the central executive is under 
greater demand. This is in fact the case, as demonstrated when 
increased speed of processing is required (Cunningham and Brookbank, 
1988; Meyer and Rice, 1989).
1.4 .2 INTER-INDIVIDUAL VARIABILITY IN DECLINE
Even though mean secondary memory test performance has been shown 
to decline with age, this could signify the whole population's 
performance gradually deteriorating or only a proportion declining rapidly 
while the performance of others remains stable. In fact, in cross- 
sectional studies, as the mean performance decreases with age, the 
variance increases, suggesting great variability between individuals in the 
rate of decline (Rabbitt, 1992). Some studies of elderly people show 
individuals performing as well as young controls (Bushke and Grober,
| 1986; Arenberg, 1990).
I
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This variablility was also shown in a 7 year prospective study of healthy 
elderly people (Schaie, 1990). Using a variety of cognitive tests, Schaie 
showed that for some tests there was a decline in mean scores for 
people in their 50's, and for all tests in 60 to 70 year olds. If significant 
deterioration was defined as being a decline of 1 SD from baseline 
scores, then by age 81, incidence of deterioration on particular tests was 
between 30%  and 40% . Conversely, between 60-85%  of people 
remained stable or improved on specific abilities, and very few people 
had global decline in all areas.
1.4.3 THE IMPACT OF AGEING-RELATED MEMORY CHANGES 
ON EVERYDAY LIFE
Although there may be changes in secondary and primary memory with 
ageing, there is evidence that poor retrieval tends to relate to routine 
rather than important information (Niederehe and Yoder, 1989). This is 
perhaps why although reported memory decline is very common in 
community residing elderly people, only a minority regard the memory 
change as a nuisance (Sunderland et al, 1986).
Semantic memory appears to be relatively well preserved (Cunningham 
and Brookbank, 1988; Bowles et al, 1989), which will help elderly people 
when in familiar surroundings and may help compensate for losses in 
other cognitive areas. Craik reports several studies demonstrating that 
elderly people use the context of information to be retained to a far 
greater extent than young people and that if this context is given in 
testing situations, ageing related differences are greatly reduced (Craik,
1990). The older person has wider life experience, and has had a greater 
chance to learn information and skills relevant to their lifestyle. Since
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some of the changes in memory may relate to lack of practice induced by 
limited social demands, it is of interest that age related effects in 
inductive reasoning and verbal meaning demonstrated by Schaie between 
middle aged and elderly cohorts were no greater than that which can be 
achieved by educational intervention, ie training (Schaie, 1990).
Therefore, although primary and secondary memory does decline with 
age in parallel with other cognitive functions, the changes are not 
universal and do not necessarily affect a person globally. Ageing-related 
changes are not as great in magnitude as those which occur through 
interpersonal variation in IQ or in training. Often, people simply 
restructure their environments and lifestyles to accommodate to these 
changes, and other cognitive factors related to ageing may help 
compensate for losses in memory performance. Many elderly people 
accept the changes associated with becoming old as natural. In a study 
of human ageing, Perlin and Butler (1980) found that all subjects had 
experienced an identity crisis in terms of sensing themselves as old, but 
reported that "..finding oneself old has been a normative crisis, not an 
affliction, for most if not all of our subjects".
However, it has been noted that the effects of a decline in memory may 
be profound for some people, particularly those in employment or with 
intellectually demanding leisure activities (Crook et al, 1986).
1.5 Neurobiology of normal ageing
Ageing affects most if not all of the major physiological systems in the 
body (Brocklehurst, 1973). Typical ageing-related changes in these
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systems have been described as a decreased ability to maintain 
homeostasis under conditions of physiological stress (Davies, 1990).
In animal nervous tissue, histological changes associated with ageing 
have been reliably reported at the subcellular level, and are similar across 
a wide range of species (Bellamy, 1985). The difficulty of assessing the 
neurobiological changes of normal ageing in the human central nervous 
system is that the tissue for analysis is not easily available. Brain tissue 
can only be obtained at post mortem, or rarely at biopsy, both of which 
are unusual in healthy elderly people. Accurate information is therefore 
sparse, but a synopsis of some of the main and reliably found changes 
will be presented.
1.5.1 MACROSCOPIC CHANGES
Brain weight decreases with age, particularly from the age of sixty 
onwards (Cole, 1985). Cortical atrophy is maximal in the frontal and 
temporal association cortex (Morris and McManus, 1991). This atrophy 
can be seen as ventricular dilatation and sulcal widening using magnetic 
resonance imaging and computerized tomography (CT), with a shift in the 
electroencephalogram pattern to lower frequency activity in healthy 
elderly adults (Obrist, 1980). There is increasing variability in brain size 
with age (Jernigan, 1987; Morris and McManus, 1991), and one-off CT- 
derived measurements of brain structures are unhelpful for differentiating 
normal and demented groups of people (Bird et al, 1986). Medial 
temporal lobe thickness, assessed by CT, declines exponentially with age 
in people with no evidence of cognitive dysfunction (Jobst et al, 1992).
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1.5.2 MICROSCOPIC CHANGES
At the cellular level, the cortical atrophy seen in the frontal and temporal 
association cortex appears to be due in the most part to reduced size of 
neuronal cells rather than reduced numbers (Morris and McManus,
1991). There are modest age-related losses in specific cell populations in 
the cortex and neuroglia numbers increase in these areas (Brody, 1987). 
Most subcortical nuclei show no reduction in number of neurones, except 
catecholaminergic nuclei containing melanin (locus ceruleus and 
substantia nigra). Cellular abnormalities such as neuritic plaques, 
neurofibrillary tangles, Lewy bodies, lipofuscin and amyloid are often 
seen in the brains of cognitively normal elderly people, though their exact 
relationship to disease states remains unclear. Alzheimer-type changes 
are certainly common in non-demented elderly people, and are more 
common than could be expected if they were early manifestations of 
Alzheimer's disease (Ulrich, 1985).
Cellular changes in the nucleus basalis of Meynert (nbM) are of particular 
interest because of the nucleus' cholinergic output and the dramatic loss 
of cells seen here in Alzheimer's Disease (Bartus et al, 1982). In a group 
of neurologically intact and pathologically normal patients (De Lacalle et 
at, 1991) it was estimated that compared to young adults, 26%  of nbM 
neurones are lost by the age of 60 and 50% by the age of 100. This 
decrease in cell number was found to be accompanied by increased cell 
size up to the age of 60, after which cell size also decreased. The 
authors suggested that neuronal plasticity was lost at around the age of 
60, and benign memory impairment is seen because the brain can no 
longer compensate for the ageing-related cell loss.
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1.5.3 BIOCHEMICAL CHANGES
Of all of the neurotransmitter and neuromodulator systems, the 
cholinergic system has received the most research attention because of 
its importance in memory dysfunction and Alzheimer's disease in 
particular (Bartus et al, 1982). Little or no change is found in the activity 
of choline acetyltransferase with normal ageing. However, there is 
reduced acetylcholine release on laboratory induced stimulation, and 
postsynaptic muscarinic receptors are probably reduced in number and 
less plastic (ie they cannot up- or down-regulate so efficiently) (Muller et 
al, 1991).
Age-related cholinergic dysfunction will of course interact with age- 
related changes in other neurotransmitter systems which are starting to 
be described (Decker and McGaugh, 1991). Neuronal cells become less 
sensitive to acetylcholine but not to glutamic acid, arguing against a 
generalized decrease in neurotransmitter system activity with ageing. 
Levels of gama-aminobutyric acid are significantly reduced, but little 
change in somatostatin is seen (Roth, 1986). 5-hydroxytryptamine (5- 
HT) turnover is probably increased, and numbers of 5-HT receptors are 
reduced (McEntee and Crook, 1991). The concentrations of 
noradrenaline and dopamine are reduced, and there may be impaired 
regulation of adrenergic receptors (McEntee and Crook, 1990). 
Metabolites produced from turnover of the monoamines are not reduced 
however, suggesting that increased turnover compensates for the 
decreased total neurotransmitter pool (Gottfries, 1992). There appears 
to be a slight decrease in brain lipid, carbohydrate, protein and mineral 
content with ageing (Samorajski and Persson, 1985).
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Although a direct link between the described changes in neurobiology 
with normal ageing and the cognitive changes described by AAMI cannot 
yet be proven, it would not seem unreasonable to assume that they are 
connected.
1.6 Benign senescent forgetfulness
Before examining the concept and diagnostic criteria for AAMI, the 
condition Benign Senescent Forgetfulness (BSF) will be described in some 
detail. This term is already widely used in the UK to describe elderly 
people with poor memories who are not suffering from dementia, and 
BSF was the direct forerunner to AAMI. There are differences in the 
groups as described however, which need to be explored.
1.6.1 STUDIES BY KRAL
Krai (1958) first suggested the terms "benign" and "malignant" 
senescent forgetfulness to differentiate a relatively stable "mild" type of 
memory impairment from an "amnestic" type which had a definite and 
sometimes rapid progress. He initially performed psychiatric and 
neurological examinations on all 162 residents (mean age 79 .4  yrs) of the 
Hebrew Old People's and Sheltering Home in Montreal (Krai, 1958). 
43 .2%  of the population had neurological signs of cerebrovascular or 
degenerative disease, and 35.2%  had signs of hemiparesis. It is unclear 
what formal cognitive testing was used as part of the assessment 
procedure.
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Krai divided the residents into 5 groups on the basis of their mental state: 
Group A were well preserved intellectually with no signs of functional 
illness; group B were felt to have "mild" memory impairment, which was 
intermittent with no clinically ascertainable memory defect; group C 
included residents without memory defect but with a past or present 
history of functional mental illness; group D he described as having an 
amnestic syndrome, with defects in at least recent memory, orientation 
and remote memory; group E resembled group D but psychotic signs 
were also present.
Krai (1962) followed up a subgroup of 94 of this population 4  years later, 
though it is unclear how this group related to the original subjects. He 
demonstrated a significantly higher mortality rate in people with an 
amnestic type of memory impairment, but no significant difference 
between the "normal" group and the group with "mild" memory 
impairment (which he now labelled as benign senescent forgetfulness). 
He later reported that in this follow-up period only one of 20 BSF patients 
developed the amnestic syndrome (Krai, 1978).
Krai performed a second study, in the geriatric service of a mental 
hospital (Krai et al, 1964). 695 patients were seen who had a total of 
1290 assessments between them during a three year observation period. 
Four diagnostic groupings were considered: senile psychosis,
arteriosclerotic psychosis, schizophrenia, and manic-depressive 
psychosis. The average length of stay for schizophrenic patients was
31.2 years and for people with manic depression 14.0 years. The 
"functional" groups (schizophrenia and manic-depressive psychosis) were 
considered to have no memory problem or the benign type of memory 
impairment. Death rates were higher for the "organic" groups (56%)
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compared to the "functional" groups (19%). The organic group's 
functional ratings mostly declined with time whereas the functional 
group's ratings generally improved, perhaps because of sustained 
therapeutic involvement. He reassessed these patients 5 years later, and 
found the death rate still to be significantly higher in the amnestic group 
(Krai, 1978).
1.6.2 THE CLINICAL DESCRIPTIONS OF BENIGN AND MALIGNANT 
SENESCENT FORGETFULNESS
Benign senescent forgetfulness, as described by Krai, is characterized by 
an intermittent difficulty in recalling specific facts. There is no distinction 
between recent and remote memories in the difficulty of recall, but 
personal experiences seem to be recalled better than facts with less 
personal meaning. Subjects tend to remember an experience itself but 
forget relatively unimportant detail. Krai felt that the prime defect was in 
recall, although he acknowledged that a variety of factors could be 
responsible for this. These included the time lapse since the event or the 
last recall of the event, modifications of the retained information during 
retention, and dynamic factors operative at the time of recall. The 
memory impairment is not accompanied by confabulation or 
disorientation and remains relatively stable in both character and severity.
In contrast, Krai characterised the malignant form as an impairment 
particularly of recent memory, including personal experiences. 
Disorientation is present, especially of time, and confabulation is found 
early on in the disorder. This type of memory impairment is progressive, 
often rapidly. In time, Krai's concept of malignant senescent
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forgetfulness developed into the amnestic type of memory impairment 
and he subsequently incorporated it into Alzheimer's dementia.
1.6 .3  CRITICISMS OF THE CONCEPT OF BENIGN SENESCENT 
FORGETFULNESS
Krai's senescent forgetfulness groups were defined by comparison with 
an unimpaired "normal" peer group. The proposition of BSF therefore 
suggests that a non-dementia memory disorder exists in a subset of the 
elderly population distinct from normal ageing. Although he identified a 
"normal" group he did not produce objective criteria to distinguish BSF 
from normality, and additionally described BSF as an expression of a 
"senium naturale" (Krai, 1978). He also did not rule out the possibility 
that BSF was part of the same neuropathological process as Alzheimer's 
disease, possibly differing in severity or location of the disease process.
The populations Krai studied were plainly not representative of the 
general population. Many healthy elderly people have transient memory 
retrieval problems, but these people were not examined. Nursing home 
residents and chronic psychiatric hospital patients are likely to have had 
other physical and mental health problems which could have caused 
memory impairment. It is difficult to extrapolate from these to the elderly 
population at large. No distinction was made between people with 
chronic problems and problems of recent onset, though if the impairment 
described is distinct from both normality and dementia, and non­
progressive, the question must be raised as to how the deficit came 
about. It is possible that many of these patients had long standing 
cognitive impairment from a variety of causes that often result in 
misdiagnosis of dementia (Spear Basset and Folstein, 1991).
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1.6 .4  RECENT WORK
Despite the methodological limitations of some of Krai's research, more 
recent work has added weight to Krai's proposition of a mild memory 
disorder distinct from normality and dementia.
Larrabee et a! (1986) carried out a series of cognitive tests on a 
population of healthy elderly people. Cluster analysis revealed a 
subgroup of subjects, who, despite globally intact intellectual ability, had 
reduced verbal and visual memory performance. These differences were 
particularly pronounced on retrieval tasks and indicated, in keeping with 
Krai's view, an intermittent rather than a consistent long term retrieval 
problem. On reassessment one year later there was no differential 
change in test scores for the control and senescent forgetfulness groups. 
However the numbers in the study were small and there was only a short 
follow-up period. Larrabee and Crook (1989) also used cluster analysis, 
on age-residualised scores from computerized cognitive tests on a larger 
group of normal elderly volunteers, to reveal a forgetful group that 
tended to be older.
O'Brien et al (1992) followed up 68 patients who originally had given a 
history of memory difficulties suggestive of Krai's BSF at a memory 
clinic, where cognitive testing revealed normality or benign age-related 
memory changes. No subjects who were felt to be suffering from early 
dementia or other psychiatric disorder were included. After a mean 
follow-up period of 3.1 years 64 patients were traced and 55 returned 
for follow-up. Telephone and/or GP contact did not reveal any of the 
non-attenders to be suffering from dementia. There were 6 new cases of
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dementia, which, although more than double the expected number, was 
not significantly raised statistically.
The Global Deterioration Scale (Reisberg et al, 1982) is a clinical 
instrument reflecting the continuum of clinical presentations between 
normal ageing and severe dementia. It is divided into 7 stages from 
stage 1 (no cognitive decline - clinical phase normal) through stages 4  
(moderate cognitive decline - clinical phase late confusional) and 5 
(moderately severe cognitive decline - early dementia) to phase 7 (very 
severe cognitive decline - clinical phase late dementia). GDS 2, the 
phase of forgetfulness, is characterized by subjective but not objective 
cognitive deficits and GDS 3 is an early confusional stage with mild 
deficits evident on careful clinical testing. GDS 2 and 3 probably 
describe subjects who would have been classified by Krai as suffering 
from BSF.
Reisberg et al (1983; 1986) studied 106 community residing elderly 
people over a mean of 3.6 years, 72 of whom were in the GDS 2 or GDS 
3 stages. All 40 of GDS 2 subjects were still community residing at 
follow-up, and only 2 had declined more than 1 GDS stage. Of 32  
subjects originally in GDS 3, 1 had died, 1 was institutionalised and 
amongst the other 30, 3 had clinically improved and 3 deteriorated. 
There was a divide then, with subjects in GDS 4 having a worse 
prognosis; of 22 subjects, 6 were dead, 6 institutionalised, and of the 
remaining 10 community residing subjects, 4  were more than 1 stage 
worse. This suggests that the majority of people with subjective and 
mild objective memory impairment have relatively little deterioration 
compared to a more impaired group who are probably in the very early 
stages of Alzheimer's disease.
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1.7 Age-associated memory impairment
1.7.1 THE ORIGINAL PAPER BY THE NIMH WORK GROUP
The term "age-associated memory impairment" (AAMI) was proposed, 
with diagnostic criteria, in 1986 by a Work Group of the National 
Institute of Mental Health in the United States, "to describe the memory 
loss that may occur in healthy, elderly individuals in the later decades of 
life" (Crook et at, 1986). The authors' stated aim was to distinguish the 
sufferers from those who experience no such loss and from those whose 
impairment is associated with other "specific" disease states. Although 
the work group included NIMH representatives and researchers in the 
fields of medicine and psychology, almost half of the 46 members were 
affiliated to various pharmaceutical companies.
The work group (Crook et at, 1986) felt that the term Benign Senescent 
Forgetfulness was imprecisely defined, with little psychometric 
assessment as part of its definition, and described a particular subset of 
older people with memory impairment. They queried the use of "benign" 
to describe what to some people is distressing and disabling and felt that 
the lack both of agreement on terminology and of specific diagnostic 
criteria made research and scientific communication difficult.
The work group's paper reviewed research into ageing-related changes in 
memory, and concluded that memory does decline, in parallel with other 
cognitive functions that make up fluid intelligence. It is notable though, 
that memory, rather than other cognitive loss, is focussed on in both the 
diagnostic criteria and the term AAMI itself. The authors felt that many 
healthy elderly people are distressed by an ageing-related decline in
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memory and are not reassured by doctors telling them that they are not 
suffering from dementia, or that it is a normal part of ageing. The work 
group thought that this advice is partly given out because of the lack of 
effective treatment for the disorder and suggested that "..it would seem 
appropriate to recognize the distress that frequently lies behind 
complaints of memory loss in the elderly and recognize the importance of 
developing effective treatments."
Evidence for ageing-related memory loss in other mammals and ageing- 
related changes in human neurobiology was reviewed. The work group 
considered that the ageing-related neuropathological and neurochemical 
changes that exist are probably quantitatively rather than qualitatively 
different from Alzheimer's disease. They therefore considered that 
compounds that reverse the relevant neurochemical deficits may be of 
therapeutic value in both AAMI and dementing disorders.
AAMI was proposed by the group "..to describe memory decline with 
age". It is to be characterized by complaints of everyday memory 
impairment with evidence of impairment on psychometric tests. 
Although the diagnosis is limited to people over the age of 50 it was not 
thought to be necessarily any different from that found in younger adults. 
AAMI can progress, but marked progression would exclude subjects from 
the diagnosis.
Proposed diagnostic criteria were then listed in the paper "for selecting 
research participants", and a copy of these may be found in Appendix 1. 
The criteria include memory complaint as "subjective evidence" of 
decline, backed up with memory test performance worse than 1 standard 
deviation below the mean for young adults as objective evidence. Other
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diagnostic criteria require adequate intellectual ability and absence of 
other possible specific medical and psychiatric causes of memory 
impairment. The working group did not intend the diagnostic terminology 
and criteria to be definitive, and expected alterations as further research 
was carried out.
1 .7 .2 RECENT WORK
McEntee and Crook (1990) suggest that AAMI may be present in most 
people over the age of fifty. Most of the published work on AAMI has 
been on highly selected samples of people of above average intelligence 
and educational background (Crook et a/, 1990^; Crook et at, 1990®; 
Crook and Larrabee, 1991). Based on data generated from these studies, 
Crook and Larrabee (1991) estimated that 70% of 50-59 yr olds, and 
91%  of 70 yr olds would satisfy the memory performance inclusion 
criteria on one test of secondary memory.
No prevalence studies using the originally suggested diagnostic criteria 
have been reported, though there are three studies from which the 
prevalence can be estimated. Reinikainen et a/ (1990) used some of the 
inclusion criteria in a group of 67-77 year olds and found 56%  to satisfy 
these criteria. Smith et a/ (1991) used most of the diagnostic criteria but 
had previously screened their over 55 year-olds for memory complaint 
and relevant medical conditions. 49%  satisfied their criteria. Lane and 
Snowdon (1989) used most of the inclusion diagnostic criteria but 
performed no physical assessments or investigations on their over 65- 
year-old subjects. They estimated a prevalence of 35%  in this 
population.
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1.7 .3 CRITICISMS OF THE CONCEPT AND DIAGNOSTIC CRITERIA OF 
AAMI
Although the attempt to recognize the problem of ageing-related memory 
change and to operationalize the diagnosis has been welcomed (Dawe et 
at, 1992) much of the published response to the NIMH work group's 
paper has been critical (Bamford and Caine, 1988; Rosen, 1990; O'Brien 
and Levy, 1992; Barker and Jones, 1993A).
The original description of AAMI is confused both in the text and in the 
proposed diagnostic criteria. The confusion is compounded by the lack 
of any discussion as to why these particular criteria were chosen. It is 
not entirely clear whether AAMI aims to define the subgroup of elderly 
people with memory changes that are commonly seen in normal ageing, 
the subgroup who are distressed by these changes, or "to describe 
memory decline with age" (Crook et at, 1986). The question as to the 
relationship to dementia is unresolved since it is to be distinguished from 
Alzheimer's disease but the similarity in neurobiology between the 
disorders has been stressed (Crook et at, 1986; Crook, 1989).
Smith et a! (1991) have rightly commented that since AAMI is supposed 
to be describing normality, then the use of "impairment" in the diagnostic 
label is misleading and perhaps "decline" would be more appropriate. 
Rosen has suggested using the term "definitional" rather than 
"diagnostic" criteria to avoid any implication that AAMI is a disease state 
(Rosen, 1990).
Other criticisms have extended from the concept of diagnosing and 
suggesting drug treatment for what is essentially normality, to details of
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the individual criteria used. Criticisms of the concept and diagnostic 
criteria of AAMI will be expanded upon in Chapters 2 and 6.
Despite critical reviews, it seems likely that AAMI will appear in some 
form in DSM-IV, perhaps under the name Ageing-Associated Cognitive 
Decline (AACD) (Caine, 1993). Pharmacological treatment trials are 
underway for AAMI despite the untested validity of the disorder, and a 
few  have been reported (Crook and Lakin, 1991; Crook et a/, 1991; 
McEntee et a/, 1991). This is of concern to some physicians (O'Brien 
and Levy, 1992; Barker and Jones, 1993®).
1.8 Summary
In this chapter methodological problems in carrying out research into 
ageing-related phenomena have been described. Despite these, evidence 
suggests that ageing-related changes do exist in memory and cognition, 
and in central nervous system neuropathology and neurochemistry, 
though their relationship to dementia has not yet been fully elucidated.
AAMI has been proposed to describe the condition of ageing-related 
memory impairment. There have been criticisms of the concept of 
diagnosing normality and of the criteria suggested to identify subjects. 
No prevalence study has yet been performed using all of the diagnostic 
criteria. Despite criticisms, some pharmacological treatment trials have 
already been reported, and AAMI is likely to appear in some form in the 
forthcoming version of DSM-IV.
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1.9 Aims of thesis
The aims of this research project were three-fold:
1. To perform a prevalence study of AAMI.
2. To examine the concept and diagnostic criteria of AAMI.
3. To assess factors affecting the presentation of people with
memory complaint to a self-referral memory clinic.
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CHAPTER 2
A PREVALENCE STUDY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
2.1 Introduction
In Chapter 1, evidence from psychological and neurobiological 
assessment was presented, which, despite the methodological problems 
discussed, suggests that ageing-related changes in memory do exist and 
that they are likely to be related to underlying neurobiological changes.
Classification of ageing-related memory decline was discussed with 
particular reference to Age-Associated Memory Impairment (AAMI) 
(Crook et al, 1986). No prevalence study of AAMI has yet been 
performed using all of the proposed diagnostic criteria (which can be 
found in Appendix 1). Despite criticisms of the concept and diagnostic 
criteria chosen, pharmacological treatment trials for AAMI are underway 
and some have reported positive results (Crook and Lakin, 1991; Crook 
et al, 1991; McEntee et al, 1991). AAMI is likely to appear in some form 
in the forthcoming version of DSM-IV (Caine, 1993).
It is therefore vital to carry out a prevalence study of AAMI in the general 
population and to critically examine the proposed diagnostic criteria. Of 
particular interest are factors involved in memory complaint, since these 
will affect not only diagnosis but also the decision of patients to present 
to clinicians for help.
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Although the inclusion criteria for a diagnosis of AAMI require memory 
complaint, it is not clear whether the work group really meant 
"complaint" or "report". Memory complaint which is distressing enough 
to motivate a person to seek medical help is clearly different from a 
report elicited in response to a questionnaire in a prevalence study. The 
Memory Assessment Clinics Questionnaire (MACQ) (Larrabee et al, 1992) 
is the only memory complaint questionnaire designed for AAMI, but this 
purely asks subjects to report any changes in memory noted (see 
Methods, section 2.2). Memory complaint should surely include both 
recognition of memory impairment and some expression of dissatisfaction 
or distress. Therefore, in the present study an additional question was 
added to enquire how distressing this change was felt to be. Hereafter, 
when the term memory complaint is used, it should be interpreted to 
mean a combination of report and distress, ie distress expressed because 
of a perceived memory impairment.
Limitations in the use of self-report questionnaires when studying 
cognitive ageing have been noted elsewhere (Rabbitt and Abson, 1990). 
These include the problems of assessing people with varied insight, the 
difficulty of validating reports of memory decline, and the effect of an 
individual's personality and affective state on memory complaint. There 
is some evidence that self-reports of memory dysfunction are poorly 
correlated with objective test performance, and more closely related to 
psychiatric symptomatology (Bassett and Folstein, 1993) and in particular 
depression (Popkin et al, 1982; O'Connor et at, 1990; Bolla et al, 1991). 
To examine this further, measures of depression and anxiety were 
included in the current study's methodology.
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The only other test used in the methodology which requires explanation 
is the National Adult Reading Test (NART) (Nelson, 1982). The 
Vocabulary subtest of the Wechsler Adult Intelligence Scale (WAIS) 
(Wechsler, 1955) is suggested in the original diagnostic criteria to 
measure intellectual function. Both tests measure verbal intelligence. 
However, the NART is more resistant to a variety of clinical conditions 
associated with increased age (Crawford et at, 1988), and is generally 
preferred amongst UK workers (Crawford, 1992). It is used in addition 
to the WAIS Vocabulary subtest in the present study.
The rest of this chapter describes a pilot study and then the main 
prevalence study of AAMI using the diagnostic criteria as suggested by 
the NIMH work group. Several of the individual diagnostic criteria are 
critically examined. Further discussion of conceptual and treatment 
issues in AAMI will be found in Chapter 6.
2 .2  Methods for the pilot study
The methodology was tested in a pilot study on a sample of 10 subjects 
over a two week period in May 1992. Following this, the main study 
recruitment took place and was completed by June 1993. All 
methodology was passed by the Bath District Health Authority Ethics 
Committee.
A copy of the AAMI diagnostic criteria used with cutoff scores for the 
relevant cognitive tests can be found in Appendix 1. Copies of the 
introductory letters, consent form, questionnaire and interview schedules 
can be found in Appendices 2 to 7.
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2.2.1 SUBJECT SELECTION
General Practitioners from the Combe Down surgery, The Avenue, 
Combe Down, Bath, provided the names and addresses of all patients
registered with them who were fifty years old and above. The subjects
were divided by sex and then grouped into nine, 5-year age bands (BO- 
54, 55-59 etc) up to 90-94. This age band was chosen as the upper 
limit, since for the main study, 20 subjects were to be chosen from each 
age band, and there were fewer than 20 patients over the age of 94
registered with the practice. For the pilot study a group of 10 subjects
was chosen which consisted of the first two names in alphabetical order 
from alternate age bands (i.e. including subjects from the youngest and 
oldest age groups).
2 .2 .2  SUBJECT RECRUITMENT
Subjects were initially contacted by letter with a covering note of 
introduction signed by all four of the Practice's General Practitioners. 
Then direct contact was made, either by telephone or if necessary by 
calling at the home, to inform subjects about the study and to ask for 
their participation. Those consenting to take part were sent a 
confirmatory letter of the agreed appointment time and a questionnaire 
which the participants were requested to complete prior to the interview. 
Any reason given for not participating was recorded, as were the age 
and sex of non-participants, in order to check for respondent bias.
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2 .2 .3  QUESTIONNAIRE DETAILS
The questionnaire included demographic details, past and present health, 
and contained measures of memory complaint, depression and anxiety. 
Subjects were requested to complete the questionnaire just before the 
interview if possible and were asked to try to be as honest as possible. 
The time taken by subjects to complete the questionnaire varied between 
around twenty minutes to an hour.
2.2 .3 .1  Memory complaint questionnaire
The memory complaint questionnaire was based on the MACQ (Larrabee 
et al, 1992), devised for quantifying memory complaint in clinical trials 
for AAMI. It asks subjects to rate how their memory has changed since 
their secondary school or college days on 7 everyday memory tasks. 
Possible scores range from 7 to 35, with a score of 21 representing no 
change, and higher scores indicating more decline. A score of 25 or 
above is considered to represent significant memory complaint and this 
level is used for inclusion into clinical trials. An additional question was 
added (the distress scale) which enquired how distressing the change 
was felt to be (rated 1 - not at all, to 5 - very much).
2 .2 .3 .2  Geriatric Depression Scale
Subjects then completed the Geriatric Depression Scale (GDS) (Yesavage 
& Brink, 1983), a simple Yes/No self-report questionnaire designed 
specifically for use in elderly people which has been found to be valid in 
medically ill and cognitively impaired individuals (Koenig et al, 1988; 
O'Riordan et al, 1990). Possible scores range from 0 to 30 with higher
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scores indicating more depression. A cutoff score of 11 has been 
suggested to indicate possible depression (Brink et al, 1982), though 
scores may be higher when self-administered rather than staff- 
administered (O'Neill et al, 1992^).
2 .2 .3 .3  State-Trait Anxiety Inventory
The Spielberger State-Trait Anxiety Inventory (Spielberger et al, 1983) 
was included in the questionnaire because it is a very widely used 
instrument for the assessment of current and trait anxiety and has been 
validated for use in elderly people (Patterson et al, 1980). Subjects are 
first instructed to rate on a four point scale how closely 20 statements 
regarding feelings about oneself relate to their own feelings at the time of 
completing the test (state anxiety, STAI-S). A second set of statements 
follows (some the same, some different) with the instruction to rate how 
much the statements relate to how they generally feel (trait anxiety, 
STAI-T).
Trait anxiety is equivalent to the personality dimension described by the 
terms neuroticism and negative affectivity (Jorm, 1989). Neuroticism 
may be important in the presentation of unexplained physical symptoms 
(Costa and McCrae, 1987; Goldberg and Bridges, 1988). Since memory 
complaint in previous work had been shown to be poorly correlated with 
memory performance (i.e. symptoms of memory impairment were not 
explained by objective assessment), it was felt a measure of trait anxiety 
would provide a valuable insight into the nature of memory complaint.
The Spielberger measure of trait anxiety presumes to measure a relatively 
stable construct. However, the Trait scale measures the tendency to
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perceive stimuli as threatening and thereby producing state anxiety 
symptoms. The state-trait model of anxiety therefore predicts closer 
correlations between the two in social-evaluative situations (Spielberger 
et al, 1983) and when self esteem is threatened (Spielberger, 1972). 
Test-retest correlations are closer for the Trait scale than for the State 
scale however (Thompson, 1989), and the Trait scale shows good 
correlation with other trait anxiety, neuroticism and negative affectivity 
scales (Jorm, 1989).
2 .2 .4  INTERVIEW DETAILS
At the interview, written consent was obtained and any difficulties in 
completion of the questionnaire were attended to. Several cognitive 
tests were then performed according to procedural instructions provided 
with manuals wherever these were in existence. Training had been
received in the administration of these tests from experienced
practitioners.
2.2.4.1 The Mini-Mental State Examination
All participating subjects first underwent the Mini-Mental State
Examination (MMSE) (Folstein et al, 1975), a widely used cognitive test 
designed to screen for the presence of dementia, with scores less than 
24 out of 30 suggested to indicate probable dementia. People scoring 
below 24 are excluded by the AAMI criteria, though the suggestion to 
raise this cutoff for exclusion to 26 or less (Crook, 1989) is examined in 
the results section. If it was clearly evident that a subject was suffering 
from dementia, they were not asked to proceed further, and subjects
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(and carers where appropriate) were advised that they could withdraw  
their consent at any point in the interview without pressure to continue.
2 .2 .4 .2  Measures of verbal intelligence
The Vocabulary subtest of the Wechsler Adult Intelligence Scale (WAIS) 
(Wechsler, 1955) and the National Adult Reading Test (NART) (Nelson, 
1982) were then administered. The WAIS, although recommended in the 
original AAMI criteria (Crook et al, 1986), was not referenced. In a later 
publication reference is made to the 1955 version of the test (Wechsler, 
1955) rather than the revised version (Wechsler, 1981), so in the present 
study the 1955 version was used.
The Vocabulary subtest of the WAIS (WAIS Vocab) consists of a list of 
40  words which are read out loud while being shown to the subject. The 
subject is asked for the meaning of the word and their responses are 
rated against a set of scoring criteria and examples given in the manual. 
The rater can prompt in a neutral way if they are uncertain whether the 
subject knows the meaning of the word. A "raw" score is produced that 
can be converted to a "scaled" score, which compares the raw score to 
the mean performance of a reference group of 20-34 year olds. Scaled 
scores vary between 0 and 19 with a mean of 10 and a standard 
deviation of 3. Estimated fullscale IQ (VOCABIQ) can be computed using 
Nelson and McKenna's (1975) regression equation.
The inclusion criteria for AAMI suggest a cutoff raw score and scaled 
score. However, the raw and scaled scores suggested do not equate in 
either the 1955 or the 1981 version of the WAIS across the age range 
proposed, and it is unclear whether one or both scores should be met for
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inclusion. For the present study the diagnostic criterion of a scaled score 
of at least 9 was used.
The NART consists of a list of 50 words to be slowly read out loud by 
the subject. These pronunciations are marked as correct or incorrect, 
and the total error score converted to estimated full scale IQ (NARTIQ) 
using Nelson's (1982) tables.
2 .2 .4 .3  Memory tests
All three tests of secondary memory suggested in the AAMI criteria were 
used (Benton Visual Retention Test-(revised), administration A (BVRT) 
(Benton, 1963); Logical Memory subtest of the Wechsler Memory Scale 
(LOG MEM) (Wechsler and Stone, 1983); Associate Learning subtest of 
the Wechsler Memory Scale (WALT) (Wechsler and Stone, 1983). For 
the prevalence data, the cutoff score for at least one of these tests had 
to be satisfied.
The BVRT consists of a series of ten cards on which one or more 
geometric figures are displayed. The subject is shown a card for 10 
seconds. The card is then removed and the subject requested to draw a 
diagram as much as possible like the one they saw. This procedure is 
repeated for each card. The drawings are marked as correct or incorrect 
against a set of scoring criteria and examples given in the manual. 
Possible scores range from 0 to 10).
The logical memory test consists of two short stories of three sentences 
each. The first story is read out loud and then the subject is requested 
to tell the rater everything that they remember from the tale. This is then
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repeated for the second story. The responses are recorded verbatim and 
marked for accuracy against the originals. This is done by the stories 
having each been divided into more than twenty sections and the scoring 
procedure rates differently for exact replication or partial recollection of 
each section. Possible scores range from 0 to  23).
The WALT consists of a list of 10 pairs of words. These are slowly read 
out to the subject. The first word of each pair is then read out and the 
subject is requested to produce the word that was paired with it. Some 
of the pairings are easy to remember (North - South) and others are hard 
(Cabbage - Pen). The subject is informed whether they were correct or 
not after each response, and if incorrect, the correct answer is repeated 
by the assessor. This sequence is repeated for the same pairs of words 
two more times with the order changed on each occasion. The score at 
the end is the sum of the total correct "hard" responses (WALT hard) 
plus half of the total correct easy responses. Possible scores range from 
0 to  21).
2.2 .5 FOLLOW-UP INTERVIEW FOR PHYSICAL AND 
PSYCHIATRIC ASSESSMENT
If, after completion of these tests, subjects were found to be suffering 
from possible AAMI as defined by scores on the MACQ and cognitive 
tests, or were thought to be possibly suffering from dementia, a second 
interview was organised for physical and psychiatric assessment. At this 
follow-up assessment, a close friend or relative was interviewed 
wherever possible.
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A semi-structured interview was completed which had been designed to 
have particular emphasis on symptoms and signs necessary for clinical 
diagnoses of major depressive episode or dementia according to DSM III- 
R criteria (American Psychiatric Association, 1987), as well as covering 
possible medical exclusion factors for the diagnosis of AAMI. At the end 
of the psychiatric assessment a score on the Hamilton Depression Rating 
Scale (HAM-D) (Hamilton, 1967) was recorded as this is required by the 
AAMI exclusion criteria. The HAM-D is an interviewer-based rating scale 
designed for use by clinicians with training in psychopathology in order 
to rate the severity of illness in people suffering from depression. It 
includes 17 symptoms and signs of depressive illness, each of which is 
rated according to clinical guidelines (Hamilton, 1980).
A physical examination was performed and a score on the Hachinski 
Ischaemia Score (Rosen et at, 1980) recorded. This score is produced by 
assessing the presence or absence of a series of symptoms and signs 
thought to be associated with multi-infarct rather than primary 
degenerative dementia (Alzheimer's disease), and is a modified version of 
the ischaemia score originally described by Hachinski et al (1975). Blood 
samples were taken for urea and electrolytes, blood sugar, liver function 
tests (LFTs), thyroid stimulating hormone, full blood count, vitamin B12, 
folate, Treponema pallidum Haemagglutination Assay (TPHA) test and 
Venereal Disease Research Laboratories test (VDRL). All laboratory tests 
were carried out at the Royal United Hospital Bath and were requested 
through the normal channels.
A letter was sent to the relevant GP for all subjects who had the physical 
and psychiatric assessment, with results of the various tests and 
suggestions for future management if appropriate.
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2 .2 .6  DIAGNOSIS
Dementia was diagnosed according to the DSM lll-R classification of 
mental disorders of the American Psychiatric Association (American 
Psychiatric Association, 1987).
Two versions of the diagnostic criteria for AAMI have been published. 
The first set were the original criteria produced by the NIMH work group 
(see Appendix 1). AAMI diagnosed by these criteria will be referred to as 
AAM I1. This is the principal diagnosis under study. The second set 
differed slightly in the cutoffs used for the tests of secondary memory, 
and were described by Crook (1989). The cutoff for the BVRT was 
raised to 7 or less and the WALT (hard) score was suggested rather than 
the WALT total score, with a cutoff set at 6 or less . AAMI diagnosed 
by the latter set of criteria will be referred to as AAMI2.
2 .3  Results of the pilot study and subsequent
modifications to the methodology for the main study
Of the 10 subjects whose names had been selected from the practice list 
for the pilot study, 1 had died, and one was not contactable over the two  
week period chosen. Six of the remaining 8 subjects agreed to be seen. 
Two were found to be suffering from both AAMI1 and AAMI2, and none 
from dementia. The methodology was found to be generally satisfactory, 
but was amended in a number of ways. These amendments are 
incorporated into the description of the main study methodology which 
follows.
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2.3 .1  SUBJECT SELECTION
A new, up to date practice listing was obtained just prior to the 
commencement of the main study to make the list as accurate as 
possible and to minimise the effect of delay between age band 
classification and interview. To try and avoid the potential 
embarrassment of trying to contact people who had recently died, 
medical notes of selected patients were consulted just prior to contact 
being made.
A random age-stratified sample of 180 people was required; 20 subjects 
from each of the nine age bands. The list of subjects was divided by 
sex. To ensure an equivalent sex distribution in the sample compared to 
the study population the proportion of men and women in each age band 
in the practice population was multiplied by 20 and the nearest round 
number used. Subjects were selected by taking every 'n'th name where 
n = number of practice population in age band divided by the number 
required in sample. The number of males and females selected from 
each age band was is shown in Table 1.
2 .3 .2  SUBJECT RECRUITMENT
Patients were contacted in small batches rotating through the age bands, 
so that any delay between selection and recruitment would have minimal 
differential effect on the bands' mean age.
Sometimes several telephone and personal calls had to be made at 
varying times of day on different days of the week over several weeks in 
order to make contact.
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Table 1
Age band and sex distribution of study sample











2 .3 .3  INTERVIEW DETAILS
Patients generally found the time taken for testing to be acceptable, but 
to control for the differential effect of fatigue on tests performed earlier 
or later in the interview, the order of pre-existing IQ and secondary 
memory measures was reversed in the second half of the sample seen.
The cognitive testing interview and the interview for physical and 
psychiatric assessment were scheduled to fit in with the subject's and 
the investigator's commitments; a number of these were carried out in 
the evening or at the weekend because many of the younger subjects 
were working.
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Arranging two visits for cognitive and physical/psychiatric assessment 
was found to be very time consuming, and so it was decided wherever 
possible to combine the visits.
2 .3 .4  ANALYSIS
Years of education (EDUCN), MMSE, DISTRESS as a result of perceived 
memory decline and AGE were not normally distributed, therefore non- 
parametric techniques were used for these variables. For the remaining 
variables parametric statistical calculations were performed.
All other statistical procedures are described in the results section, and 
were carried out with the aid of the statistical software package SPSS- 
PC. A level of p <  0.05 was set for statistical significance and all p 
values quoted are based on a two-tailed test of significance.
2 .4  Results of the main study
2.4.1 PRACTICE DEMOGRAPHICS
The breakdown of the practice population by sex and age is shown in 
Table 2. For comparison, data is given from the Office of Population 
Censuses and Surveys for England and Wales 1991 (OPCS, 1993^). 
41 % of the total practice population are aged 50 and over compared to 
31%  of the general population. 26%  of the practice population are over 
retirement age compared with 19% of the general population. From the 
County Monitor of the same year (OPCS, 1993®) the practice population 
appears to be representative of the population of Bath, though Avon as a
51
whole is similar in age structure to England and Wales (Bath 23 .4%  of 
pensionable age or over, vs 19.4%  of Avon) (data not shown).
The sex distribution of the over 50's is similar in the practice population 
and the general population (practice population 43%  male, general 
population England and Wales 45%  male).
Table 2
Patient numbers by sex in five year age bands at Combe






England and Wales 
(thousands)
Male Female Total
50-54 211 203 414 1359.3 1357.3 2716.6
55-59 204 217 421 1280.0 1296.2 2576.2
60-64 215 234 449 1237.2 1321.9 2559.1
65-69 203 225 428 1150.4 1331.3 2481.7
70-74 178 252 430 879.5 1154.4 2033.9
75-79 134 239 373 653.2 1013.7 1667.0
80-84 92 154 246 377.6 741.6 1119.2
85-89 38 98 136 164.6 419.1 583.8
90-94 5 38 43 - - -
50+ 1281 1672 2953 7147.5 8817.6 15965.3
90+ 6 50 56 45.7 182.1 227.8
95+ 1 12 13 - - -
All
ages 3540 3679 7219 24891.5 26063.3 50954.8
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2 .4 .2  DESCRIPTION OF THE STUDY SAMPLE
Of the 180 names obtained from the practice list, 16 could not be 
approached for the study; they were effectively "missing" from the 
sample. One subject's date of birth was wrong so she was in fact too 
young to be considered for the study, and for one subject the address 
given was a UK address for somebody living abroad. 3 subjects were 
deceased and one was too ill to be seen and died in hospital shortly 
after. 7 had moved out of the area (4 into a nursing home) and 2 were 
not registered any longer but it was unclear whether they had moved or 
were deceased. One person was uncontactable; he did not have a 
telephone, and 8 visits on different days including weekends and at 
different times of the day including early morning and evening over the 
course of 6 weeks did not locate him. He did not respond to a second 
letter sent to him.
Of the remaining 164 subjects, 23 (14%) refused to help at all. Of these 
23, the most common reason given was that the person was too busy 
(8). Other common reasons given included suspicion of my intentions; 
the belief that taking memory tests would be worrying; and ill health, 
either physical or emotional. Of the 141 people who agreed to help, 7 
would only do so by answering questions over the phone or by 
completing the questionnaire part of the study. Common reasons given 
for agreeing to help with the questionnaire but not with cognitive tests 
included being too busy and feeling threatened by testing. The feelings 
of threat sometimes related to the fear of detection of early dementia, 
and sometimes to discomfort at being put on the spot and embarrassed 
at their performance. Since the group who agreed to help but not to be 
interviewed was so small, little useful data can be gleaned from them.
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Therefore they will be combined with the refusers in subsequent analysis. 
134 subjects were therefore seen out of 164 subjects in the sample 
(consent rate of 82%).
2 .4 .3  COMPARISON OF SUBJECTS "MISSING", "REFUSED" AND SEEN
The distribution of subjects not contactable "missing", subjects who 
refused, and subjects who were seen is shown in Table 3.
Table 3
Age band distribution of subjects not contactable (missing), subjects who 
refused and subjects who were seen, by age band
Age band Missing Refused Seen
50-54 5 - 13
55-59 , . -  . . 4 16
60-64 2 5 13
65-69 2 3 17
70-74 - 4 16
75-79 1 2 14
80-84 1 4 17
85-89 2 5 13
90-94 3 3 15
Total (%) 16(8.9) 30(16.7) 134(74.4)
Chi-Square 18.4 p = 0.3
The reason the row totals do not all add up to 20 is due to slippage in 
age bands because the age of the subjects when seen was used for 
analysis rather than age at randomisation (up to one year previously). 
There is no significant difference in age band distribution between the
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groups (Chi-square test) or in the mean age of the three groups (Table 4) 
with the non-parametric Kruskal-Wallis test. There was still no significant 
difference in age band distribution or mean age between the three groups 
after combining the "missing" and "refused" groups into one "not seen" 
group (Age band by seen/not seen Chi-square = 3 .4  p = 0.9; mean age 
seen vs not seen = 73.1 (SD 13.9) vs 72.8 (SD 12.6) Mann-Whitney 
Test z =  -0 .19 p = 0.9).
Table 4
Comparison of "missing" subjects, subjects who refused and subjects 
seen by age
Mean SD Cases
Missing - not contactable 70.0 16.8 16
Refused to be seen 74.7 12.0 30
Seen 72.8 12.6 134
For Entire Population 72.9 12.9 180
Kruskal-Wallis test 1 way anova, Chi-Square 1.4 p = 0.5
Sex distribution between the three groups is shown in Table 5. No 
statistically significant difference is seen. There was still no significant 
difference in sex distribution after combining the "missing" and "refused" 
groups into one "not seen" group (Chi-square = 2.7 p = 0.1).
In conclusion, these analyses indicate that the subjects who were not 




Comparison of "missing" subjects, "refused" and subjects seen by sex
Missing Refused Seen Total(%)
Female 10(9) 23 (21) 78(70) 111(100)
Male 6(9) 7(10) 56(81) 69(100)
Chi-Square 3.5 p = 0.17
2 .4 .4  STUDY WITHDRAWALS
Of the 134 people agreeing to be seen, 3 could not complete all of the 
tests due to fatigue and 6 due to physical handicaps (poor sight, hearing, 
or weakness following stroke). None of these 9 subjects were believed 
to be suffering from a dementing illness. Three could not be coded for 
the diagnosis of AAMI due to missing test data. Of the other 6, only one 
satisfied the original AAMI criteria and five did not. These nine subjects 
will not be considered further, and the rest of the data relates to the 
remaining 125 subjects.
2.4 .5 PREVALENCE OF DEMENTIA
11 subjects were found to be suffering from dementia. All were over 80; 
2 in the 80-85 group, 4  in the 85-90 group, and 5 in the 90-94 group. 6 
were classified according to DSM lll-R criteria as suffering from primary 
degenerative dementia of the Alzheimer type, 2 from multi-infarct 
dementia, and 3 from senile dementia not otherwise specified.
To check that these numbers were close to that expected, population 
prevalence rates based on these findings were calculated. Proportions of 
cases with dementia in each 5 year age band were multiplied by
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population numbers of the same age band in the Census data of 1991 for 
England and Wales (OPCS, 1993A). The resulting figures were added 
together for cross age-band prevalence rates, with the denominator the 
sum of total population numbers of the same age bands in the Census 
data of 1991 for England and Wales (OPCS, 1993A). Population 
numbers for over 90's were used for the 90-94 group multiplier because 
no data on the 90-94 age group is given in the Census. The numbers are 
so small in this age group that little significant difference would be made 
by this manoeuvre. Prevalence rates for England and Wales based on 
this calculation were estimated as 5.8%  of over 65's and 24.5%  of over 
80's. These are close to previously estimated prevalence rates and lend 
support to the adequate exclusion of dementia from the study sample.
2 .4 .6  PREVALENCE OF AAMI
Cases of AAMI were identified using the originally published diagnostic 
criteria (AAMI1 )(Crook et at, 1986) and the later modified criteria 
(AAMI2)(Crook, 1989). There was no sex difference in prevalence of 
AAMI with either definition (AAMI1 M:F = 10/55:12/70, Chi-square 0 .02  
p = 0.9; AAMI2 M:F 13/55:16/70 Chi-square 0.01 p = 0.9). Therefore no 
differential computation was performed for total prevalence rates by sex.
Distribution of cases of AAMI1 and AAMI2 by age band are shown in 
Table 6. Estimated prevalence rates based on these figures were 
calculated using the same methodology as used for the dementia rates 
described above. Prevalence rates were calculated for three, fifteen-year 
age bands, for over 50's and for the total population and are shown in 
Table 7. Fifteen-year age bands were chosen to limit the effect of 
random variation in the numbers of actual cases in individual age bands.
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Prevalence rates are shown to vary by a factor of 40%  for 50-94 year 
olds, or 50%  for 50-64 year olds depending on which set of criteria are 
used. Increased frequency of exclusion factors mainly accounts for the 
lower prevalence of AAMI seen in older age groups.
Table 6






50-54 8 5 7 6
55-59 16 - 16 -
60-64 12 1 10 3
65-69 11 6 9 8
70-74 14 1 13 2
75-79 10 4 10 4
80-84 12 1 11 2
85-89 9 2 9 2
90-94 11 2 11 2
Total 103(82 .4) 22(17.6) 96(76. 8) 29(23.2)
Table 7
Estimated prevalence rates of AAMI1 and AAMI2





All ages 5.8% 8 .0%
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2 .4 .7  PSYCHOMETRIC DESCRIPTION OF STUDY SUBJECTS NOT 
SUFFERING FROM DEMENTIA
Before examining individual inclusion criteria, the subjects with dementia 
were removed since full data was not available for these. This left 114  
subjects. Descriptive statistics of psychometric variables necessary for 
diagnosis of AAMI in these subjects are shown in Table 8.
Table 8
Descriptive statistics for psychometric variables of study subjects not 
suffering from dementia
Variable Mean SD Minimum Maximum
MACQ 24.3 4.5 7 35
BVRT 5.6 2.3 0 10
LOG MEM 6.5 2.9 1.5 13.5
WALT Total 12.2 4.1 4 21
WALT hard 4.5 3.3 0 12
Scaled score 
of WAIS Vocab 12.4 2.9 7 19
MMSE 27.7 2.1 21 30
2.4 .8  SUBJECTS SATISFYING INDIVIDUAL AAMI INCLUSION CRITERIA
The proportions of subjects satisfying various inclusion and exclusion 
criteria are shown in Table 9. A score of 25 on the MACQ is the 
suggested cutoff to indicate significant memory complaint, and 22 
indicates at least some reported overall decline. The significance of 
scoring below the cutoff score on different numbers of tests is unclear.
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The original criteria propose using a cutoff score 23 /24  on the MMSE, 
although others have suggested using 26/27 (Crook, 1989).
Table 9
Subjects satisfying individual AAMI diagnostic criteria
MACQ 55/114 (48%) scored 25 or more.
81/114 (71%) scored 22 or more.
AAMI1 MEMORY TEST CRITERIA:
BVRT 65/114 (57%) scored 6 or less.
LOG MEM 53/114 (46%) scored 6 or less.
WALT Total 69/114 (61%) scored 13 or less.
86/114 (75%) satisfied criteria for at least 1 test.
19/114 (17%) satisfied criteria for only 1 test.
33/114 (29%) satisfied criteria for 2 tests.
34/114 (30%) satisfied criteria for all 3 tests.
AAMI2 MEMORY TEST CRITERIA:
BVRT 90/114 (79%) scored 7 or less.
LOG MEM 53/114 (46%) scored 6 or less.
WALT hard 81/114 (71%) scored 6 or less.
101/114 (89%) satisfied criteria for at least 1 test.
22/114 (19%) satisfied criteria for only 1 test.
35/114 (31%) satisfied criteria for 2 tests.
44/114 (39%) satisfied criteria for all 3 tests.
WAIS Vocab 102/114 (89%) scaled score of 9 or more.
MMSE 5/114 non-demented subjects scored less than 24. 
26/114 non-demented subjects scored less than 27.
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2 .4 .9  EXCLUSION CRITERIA
Of 125 subjects with full data, 31 had memory complaint and memory 
test performance compatible with a diagnosis of AAMI1: 9 of these had 
medical or psychiatric factors that excluded the diagnosis (30% ). These 
are listed in Table 10. 11 out of 40 (28%) potential AAMI2 candidates 
were excluded because of medical/psychiatric factors.
Table 10
Subjects excluded because of medical factors
1 Transient ischaemic attack 5 and 15 years ago.
2 Heavy alcoholic intake in past and most likely in 
present - unexplained high mean cell volume. DSM 
III-R major depressive episode. HAM-D > 12.
3 Untreated hypothyroidism detected on laboratory 
screen.
4 Severe angina. Currently taking diazepam and 
propranolol.
5 Taking amitriptyline and diazepam. HAM-D > 12.
6 Diabetes, severe arteriopath - bilateral amputee. 
Taking temazepam and DSM III-R major depressive 
episode. HAM-D > 12.
7 Cerebrovascular accident (CVA). DSM III-R major 
depression, on antidepressants. Hachinski > 3.
HAM-D> 12.
8 CVA. Diabetic and hypertensive. Hachinski > 3.
9 Liver failure under treatment. History of 
haematemesis, blackouts, anaemic and abnormal LFTs 
on laboratory analysis.
61
All subjects had brief medical histories taken including current 
medication. However, only those subjects with possible AAMI or 
dementia had further physical and psychiatric assessment. 39 /125  
subjects had known medical exclusion factors including current or past 
medical illness, concurrent medication, Hachinski scores higher than 3, 
Hamilton depression rating scores of 13 or higher or psychiatric illness 
which may cause cognitive impairment. Those not already listed above 
are shown in Appendix 8.
Five people had Hachinski scores greater than 3 and all of these would 
have been excluded by medical factors in their past medical history. 
Four subjects had a DSM III-R diagnosis of major depressive episode - all 
of these and one other subject had a HAM-D score of greater than 12. 
Only one of the people with a DSM III-R diagnosis of major depressive 
episode and/or a HAM-D score of greater than 12 was not excluded for 
other reasons (physical illness, psychotropic medication).
2 .4 .10  MODIFYING THE AAMI INCLUSION CRITERIA
The MACQ was used to quantify self-reported memory decline and a 
level of 25 used to indicate significant decline. The AAMI criteria make 
no such quantification. If any reported decline whatsoever was 
considered to be significant, approximately 50%  more subjects would 
have been classified as AAMI sufferers (52% for AAMI1 and 49%  for 
AAMI2).
If, as has been suggested, the score on the MMSE for inclusion was 
raised from 24 to 27, approximately 26% fewer AAMI1 and 20%  fewer 
AAMI2 cases would have been identified.
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2.4.11 REPORTED MEMORY DECLINE AND MEMORY TEST 
PERFORMANCE IN SUBJECTS WITH AND WITHOUT 
EXCLUSION FACTORS
T-tests were performed (Table 11) for interval inclusion/exclusion 
variables between people with and without exclusion factors for AAMI 
(with the exception of the MMSE for which the non-parametric Mann- 
Whitney test was used). Reported memory loss was no different 
between the two groups. The BVRT and the MMSE were significantly 
lower for people with medical exclusion factors, there was a trend for the 
WALT score to be lower and there was no significant difference in logical 
memory score. Appendix 9 gives raw data listings for the mean score 
and SD for the variables MACQ, DISTRESS, BVRT, LOG MEM, WALT, 
MMSE, NARTIQ, and VOCABIQ in all non-demented subjects and all 
healthy subjects.
Table 11
Reported memory decline and memory test performance in subjects with 






Mean (SD) Statistic p value
MACQ 24.9(4.1) 24.0(4.6) rt II o • VO > 0.4
BVRT 4.2(2.5) 6.1 (2 .0) rt II • o > 0.0001
LOG MEM 5.7(3.1) 6.7(2.8) t= 1.7A 0.10





B Mann-Whitney test (exact p value not computed by SPSS-PC)
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2 .4 .1 2  PSYCHOMETRIC MEASURES IN SUBJECTS WITH POSSIBLE 
AGEING-RELATED DECLINE IN COGNITION
Subjects with exclusion factors according to the AAMI criteria were 
removed before examining relationships of psychometric measures in 
those for whom any cognitive decline present might reasonably be 
attributed to ageing. This left 86 subjects with data for analysis, whose 
age and sex distribution is shown in Table 12.
Table 12
Subjects with no exclusion factors according to AAMI criteria
Age band Female Male Total(%)
50-54 3 8 11 12.8)
55-59 6 7 13 15.1)
60-64 6 5 11 12.8)
65-69 9 7 16 18.6)
70-74 6 5 11 12.8)
75-79 5 3 8 9.3)
80-84 4 2 6 7.0)
85-89 3 2 5 5.8)
90-94 4 1 5 5.8)
Total(%) 46(53.5) 40(46.5) 86 100.0)
Since years of education (EDUCN), MMSE, DISTRESS as a result of 
perceived memory decline and AGE were not normally distributed, non- 
parametric Spearman rank correlations were used in the correlation 
analyses described. For the remaining variables parametric Pearson 
product moment correlations were performed.
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2.4 .12.1 The relationships between cognitive test 
performance, education and age
The correlation table of cognitive test performance and age with 
education, memory test performance and IQ is shown in Table 13. 
Unfortunately exact p values are not computed by SPSS-PC if less than 
0 .001 , so these appear as p <0 .00 1 .
Table 13
Correlation coefficients of cognitive test performance and age with 
education, memory test performance and IQ















































Strong and highly significant correlations can be seen between all of the 
memory tests with age. Verbal IQ, as estimated by the NART or by the 
Vocabulary subtest of the WAIS, is closely correlated with all of the 
memory tests and the MMSE but no significant correlation is seen
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between age and verbal IQ. Length of time in education is significantly 
correlated with all of the cognitive tests, and there is a trend for older 
people to have had fewer years of education.
2 .4 .12 .2  The relationship of cognitive test performance, 
age and education with memory complaint
No statistically significant correlations are seen between reported 
memory decline or related distress with any of the memory tests or 
MMSE (Table 14).
Table 14




































Significant positive correlations are demonstrated for NART estimated IQ 
with both reported decline and distress and between WAIS Vocabulary 
estimated IQ and education with reported decline. Reported memory 
decline and distress experienced as a result of this decline were strongly 
correlated (Spearman rank correlation coefficient = 0 .6 4 f p <  0.001).
2 .4 .12 .3  Relationship between memory complaint and 
estimated decline in memory
Memory complaint may be poorly related to cognitive test performance 
because absolute values bear no relation to decline. One way of 
estimating decline is to use the NART or WAIS Vocabulary generated IQ 
score as an estimate of original performance (Christensen, 1991). The 
NART estimated IQ is preferred in the UK as being a more reliable 
measure of pre-existing IQ (Crawford, 1992).
z scores were therefore computed for each of the short term memory 
tests and NARTIQ and differences in z scores used as an estimate of 
present versus past performance (NART z score - Test z score). Table 15 
shows correlation coefficients for memory complaint with z score 
differences between NARTIQ and memory test scores (BVRT ZDIFF, LOG 
MEM ZDIFF and WALT ZDIFF.
A statistically significant correlation is seen between both reported 
memory decline and distress as a result of this decline with LOG ZDIFF. 
This means that people with a lower logical memory score relative to 
their estimated pre-existing IQ have higher memory complaint. No 
significant relationship is seen for the WALT or BVRT.
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Table 15
Correlation coefficients of memory test performance relative to NART 
score with reported memory decline and distress experienced at this 
decline
MACQ DISTRESS
BVRT ZDIFF .14 .19
'O II o • to p=0.08
LOG MEM ZDIFF .28 .28
p=0.009 p=0.009
WALT ZDIFF .18 .15
p=0.1 p=0.2
2 .4 .12 .4  Relationship between memory complaint and 
affective symptoms
In contrast to the weak relationship between memory complaint and 
objective memory test performance, self-reported memory loss and 
distress are both significantly correlated with measures of depression and 
state and trait anxiety (Table 16). The strongest correlation is between 
trait anxiety and distress as a result of perceived memory decline.
Table 16
Correlation coefficients for reported memory decline and distress as a 
result of this decline, with affective symptoms
MACQ DISTRESS
GDS .24 .31






2 .4 .12 .5  Relationship between cognitive test performance 
and IQ with affective symptoms
There is no statistically significant correlation between state and trait 
anxiety with memory test performance or verbal IQ, though a modest 
correlation is seen between depression with BVRT and logical memory 
scores (Table 17).
Table 17

































2 .4 .12 .6  Relationship between reported memory decline, logical
memory test performance, IQ and affective symptomatology
In order to examine the relative weight of memory test performance and 
affective symptomatology in the prediction of reported memory decline, a 
stepwise multiple regression model was constructed. Reported memory 
decline (MACQ) was the dependent variable and LOG MEM score,
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NARTIQ, LOG MEM ZDIFF, and the affective symptom rating scales 
(GDS, STAI-S, STAI-T) were independent (Table 18). The LOG MEM 
score was used since this had shown the strongest correlation with 
memory complaint. Pin and pout levels were set at 0 .05 and 0.1 
respectively (pin and pout refer to the p value of the F statistic for a 
variable in order to enter or subsequently remove that variable in 
stepwise multiple regression and the levels chosen are the ones most 
commonly used).
The only variable that entered the regression equation was trait anxiety, 
and this accounted for 11 % of the variance. NARTIQ and LOG MEM 
ZDIFF were just excluded.
Table 18
Stepwise multiple regression analysis in the prediction of reported 




B (SE) BetaA T Sig T
STAI-T .22 (.07) .33 3.3 p=0.002

























pBeta = regression, coefficient
°Beta in = regression coefficient if variable were
r  entered next into equation




The aims of the project described in this chapter were to perform a 
prevalence study of AAMI and to examine some of the proposed 
diagnostic criteria for AAMI.
Total-population and over-50s prevalence rates of AAMI1 were estimated 
to be 5.8%  and 18.5%  respectively based on 1991 census data for 
England and Wales. The age and sex structure of the sample population 
seen was not statistically different from those not seen. Prevalence rates 
for dementia are very close to internationally estimated rates of around 
5% and 20%  for over-65 and over-80 year olds published elsewhere 
(Jorm et a/, 1987; Hofman et at, 1991). The prevalence rates for AAMI 
are therefore unlikely to have been distorted by either non-participant 
bias or undetected cases of dementia.
Three other studies of AAMI have been published from which estimates 
of prevalence can be made. Reinikainen et af (1990) performed the 
MACQ, MMSE, WALT and BVRT on a community sample of 67-77 year 
olds, and showed the prevalence with these criteria to be 55.8% . Smith 
et at (1991) applied most of the diagnostic criteria to a group of people 
55 years and over who had been previously screened for memory 
complaint and relevant medical conditions. AAMI was present in 49% . 
Lane and Snowdon (1989) used similar criteria to Smith et a/  on a group 
of people 65 and over, but performed no physical assessments or 
investigations. They found a prevalence of 35% . The current study 
estimate is likely to be more accurate since, with the exception of an
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ECG, the criteria used were those as originally proposed by the NIMH 
work group, with memory complaint more accurately defined and with 
subjects assessed for the presence of medical and psychiatric causes of 
memory impairment.
2 .5 .2  LIMITATIONS IN STUDY METHODOLOGY
A community prevalence study such as that described in the present 
chapter could always benefit from a larger study population, but the 
intensity and the time-consuming nature of the work required from one 
investigator precluded more subjects being seen. The fact that the 
prevalence rates for dementia were so close to internationally accepted 
values lends support to the likely accuracy of the data for AAMI.
The prevalence rates for dementia may be underestimates since, because 
of the delay between subject selection and recruitment (up to a year), a 
relatively large number of those who could not be contacted had died or 
had moved into a nursing home.
It was hoped that the STAI-S could be used as an indication of the level 
of anxiety at the time of the cognitive testing, as well as to correlate with 
memory complaint, by asking subjects to complete the questionnaire just 
before the interview. In retrospect it would have been wise to include 
this instruction on the front of the questionnaire or in the letter 
confirming the appointment, because often people had completed the 
questionnaire several days before the interview. This makes it difficult to 
draw strong conclusions about the relationship between state anxiety 
and memory test performance, though the correlations with memory test 
scores were stronger for State than Trait anxiety.
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Unfortunately, although an electrocardiogram (ECG) should have been 
performed as part of the medical assessment of people with possible 
AAMI, no portable machine was available. It is unlikely however, that in 
the absence of significant clinical symptoms or signs any subjects would 
have been excluded on the basis of an ECG alone, and there were no 
specific indications for an ECG in any of the subjects seen which would 
have altered the findings.
2.5 .3  EXAMINATION OF PROPOSED INCLUSION CRITERIA
The rates of AAMI are sensitive to the precise psychometric definition 
used. Thus the AAMI2 set of criteria, which differ only by minor 
changes in cutoff scores for the secondary memory tests, affected 
prevalence rates for 50-94 year olds in the present study by a factor of 
40% . The exact diagnostic criteria proposed therefore need to come 
under close scrutiny, particularly as there is little discussion on the 
reasons for the criteria chosen in the original document (Crook et at, 
1986).
2.5.3.1 Age
The prevalence study presented in this chapter relates to people over the 
age of fifty, as proposed in the original AAMI paper (Crook et at, 1986) 
and is therefore an advance on previous prevalence studies of AAMI 
(Lane and Snowdon, 1989; Reinikainen et alf 1990; Smith et al, 1991). 
However, if the object is to describe memory decline with age, then it is 
not clear why the age limit for AAMI was set at fifty. The work group 
acknowledged that the memory impairment defined by AAMI is not
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necessarily qualitatively different from that which occurs in younger 
adults and performance on some tests of new learning starts declining 
from the twenties (Salthouse, 1982). One could question whether it is 
reasonable to recognize a disorder only when the sufferer reaches a 
certain age. No upper limit was set for age, which supposes that the 
ageing process is similar in 50 year olds and 100 year olds. In fact the 
relative sparsity of reliable normative data above the age of 80 has led to 
the suggestion that this should be the upper age cutoff for diagnosis 
(Blackford and La Rue, 1989).
By design the diagnostic criteria for AAMI attempt to define the disorder 
by comparing elderly people with a young population, rather than with 
age-matched peers, in contrast to the disorder of Benign Senescent 
Forgetfulness (see Chapter 1). The rationale for choosing a young 
population for comparison is that this is the group that the elderly 
compare themselves to when complaining that their memory has declined 
(Crook, 1989). However, elderly people do not compare themselves to 
the young average population, but to their own previous performance at 
a younger age.
2 .5 .3 .2  Memory complaint
The diagnostic criterion of memory complaint is perhaps the most 
contentious of those proposed, since it is undefined and not quantified in 
the work group paper. In the present study, the MACQ was used, which 
is the only memory complaint questionnaire designed for AAMI which has 
a suggested cutoff score (Larrabee et al, 1992). The cutoff score, set to 
define "significant" memory complaint is presumably arbitrary. If report 
of any decline whatsoever is used to define complaint, then in the
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present study, prevalence rates are altered by a factor of approximately 
50% .
Reinikainen et a! (1990) also used the MACQ in a community study in 
Finland and found 79.8%  of 67-77 year olds to score 25 or more on the 
MACQ. This is higher than the level found in the present study, and 
suggests that memory complaint varies considerably across different 
populations even when measured identically. Abson and Rabbitt (1988) 
report a study where all 564 community residing volunteers felt their 
memory had declined with age. Unless memory complaint is defined and 
a standardised questionnaire devised for its measurement, the diagnostic 
criterion of memory complaint may markedly affect diagnosis.
The issue of whether the work group really meant complaint or report 
has been raised earlier, though as seen in the present study reported 
memory decline and distress experienced as a result of this decline are 
closely correlated. The original paper uses memory complaint as 
"subjective evidence" of memory impairment. Mild memory lapses are 
common in all age groups and do not presumably indicate impairment. 
Nor does subjective evidence necessarily imply complaint. The MACQ, 
produced by a member of the AAMI working group and used widely as 
an inclusion criterion and outcome measure for clinical trials in AAMI, 
asks for recognition of change rather than indication of distress caused.
In medical conditions, a patient's distress or complaint may affect a 
patient's decision to visit a doctor and the doctor's decision to offer 
treatment, but it is not normally a criterion for diagnosis. If it were so, a 
person who complains could be diagnosed as having the condition where 
another with identical cognitive and neurobiological states would not.
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One could question whether self reports should be used at all for 
diagnosis of AAMI, since there is little evidence from the present study 
that either reported decline or distress at a perceived decline bear any 
relation to actual memory test performance or decline. There were no 
significant correlations between MACQ score with age or memory test 
performance (Table 14) even though all three tests of secondary memory 
were significantly correlated with age even in healthy individuals (Table 
13). In contrast to this, there were significant positive correlations 
between the MACQ with years of education and verbal IQ score and with 
all three of the scales of affective symptomatology (Tables 14 and 16).
The relatively weak correlation between memory complaint and test 
performance has been shown elsewhere (Abson and Rabbitt, 1988; 
Taylor et a/, 1992), as has the stronger correlation with depression 
(Niederehe and Yoder, 1989; Bolla et al, 1991). The strong relationship 
to both state and trait anxiety adds to this work. The relationship of 
premorbid IQ with memory complaint may indicate that better educated, 
more intelligent people notice and are distressed by an ageing-related 
decline in memory since they are more likely to have intellectually 
demanding working environments and leisure pursuits.
Reisberg et a! (1988) found that a group of community residing elderly 
people with memory complaint performed better than those without 
complaint on two cognitive assessments, even though neither group had 
objective evidence of memory impairment. This was hypothesized to be 
partly due to people of higher intelligence being more troubled and 
seeking assessment earlier.
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It was of interest that the relationship between memory complaint and 
performance was strengthened when an estimate of premorbid ability 
was included (Table 15) as this has been shown previously in one small 
study (Christensen, 1991). The effect in the present study was 
strongest for the logical memory test. Story repetition has previously 
been reported to be better correlated with memory complaint (Sunderland 
et a/, 1986) than other tests, and it may be that this test is more 
ecologically valid for comparison with the MACQ than the other tests 
used.
It may be that some people who experience a decline in logical memory 
test performance are distressed by it, causing them to suffer from 
depressive and anxiety symptoms. State-Trait anxiety theory would 
predict the trait component to become more state-like in testing 
conditions like those described in the present study, so it would not be 
unexpected for the memory complaint items to correlate with the trait as 
well as the state anxiety dimension. However, correlations for the 
MACQ and DISTRESS with trait anxiety were stronger than with state 
anxiety or with depression (Table 16). Also, it was the GDS which 
correlated most strongly with memory test performance rather than the 
anxiety dimensions (Table 13). This suggests that the relationship of 
memory complaint with affective symptomatology was probably related 
to heightened general symptom reporting due to differences in 
personality rather than being related to actual decline. The relationship 
between reported decline with memory performance relative to pre­
existing IQ becomes non-significant when IQ, depression and anxiety are 
taken into consideration (Table 18). The logical memory test is the test 
most closely correlated with affective symptomatology (Table 17). It has 
been argued that this task relies heavily on attention and concentration
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and is affected by depression since information is only presented once 
(Bolla et a/, 1991). It also may be particularly demanding on the 
articulatory loop (see "working memory", Chapter 1).
Depressed patients do have problems remembering (Strack et al, 1985), 
but both memory complaints and objective memory performance improve 
with resolution of the depression (Sternberg, 1976; Frith et a!, 1983). 
However, in the present study, depressed subjects had been removed 
prior to correlations being performed (since they were classified as 
having medical exclusion factors of a DSM III-R diagnosis of major 
depressive episode or a HAM-D score of more than 12). Significant 
relationships were still seen between depression with memory test 
performance and memory complaint, suggesting that a similar effect of 
depression on memory complaint and performance exists even at a sub- 
syndromal level.
2 .5 .3 .3  Memory test performance
The significance of scoring below the cutoff score on different numbers 
of tests is unclear. If only one memory test score needs to satisfy the 
criteria, the chance of inclusion will increase with each test added, 
because of intra-individual variation over time and over different areas of 
memory prowess (e.g. verbal and nonverbal memory tests). In the 
present study 75%  of subjects satisfied one test requirement, and only 
30%  satisied all three (Table 9).
It is not clear why memory performance more than one standard 
deviation below the mean for young adults should be chosen as the 
cutoff for inclusion. Any cutofff imposed onto a continuum risks
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seeming arbitrary, and again there is no explanation of why this level was 
chosen. The cutoff scores may have been set not to delineate an 
abnormal group, but to demonstrate that memory has declined by more 
than the variation that can be expected with repeated assessment on 
brief tests such as these. This intra-individual variability over time may 
be one explanation of why, in a 2 year longitudinal study of people with 
AAMI, 7/51 (14%) had "spontaneous remission" by improving their 
memory test scores (Lane and Snowdon, 1989). When developing 
normal or reference ranges it is usual to consider values as significant if 
they are more than two standard deviations outside the mean for a 
population (Bland, 1987). If this method were applied, however, the only 
subjects identified would have a high probability of suffering from 
dementia.
2 .5 .3 .4  Adequate intelligence
No attempt is made in the diagnostic criteria to take into account an 
individual's educational and intellectual background, which in the present 
study (Table 13) and elsewhere (Schaie, 1990) have been shown to be 
strongly linked to memory test performance. In order to demonstrate 
decline, present memory should be compared to an internal and 
retrospective estimate of original cognitive functioning, such as the NART 
or the Vocabulary subtest of the WAIS.
There is no discussion as to why adequate intellectual function is 
required for the diagnosis, though it may be to remove people who had 
always had poor memory test performance due to low IQ. However, this 
will mean that only people with a relatively good vocabulary will be 
included (and hence bias diagnosis in favour of those with better
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education, from a higher socio-economic class and with English as their 
first language). It could be argued that people with very poor memory 
function to start with are at most risk from further decline.
The proposed method of indicating adequate intellectual function is by 
performance on the Vocabulary subtest of the Wechsler Adult 
Intelligence Scale (WAIS) (Wechsler, 1955). The lack of reference for 
the WAIS in the diagnostic criteria has been mentioned previously, and is 
important because the WAIS-R (Wechsler, 1981) has revised tables for 
converting raw scores to scaled scores, and has been shown to yield IQs 
that are around half a standard deviation lower than the WAIS (Crawford 
et al, 1990). Once again the suggested score appears to be arbitrary 
and, by categorising a continuous variable, an artificial boundary is 
imposed that has little meaning in real terms.
The Vocabulary subtest of the WAIS may have been chosen as a 
measure of original intellectual function because it correlates with overall 
intelligence, and performance on it remains relatively stable with ageing 
(Wechsler, 1981). The scaled score cutoff proposed for adequate 
intelligence is just less than the mean for young adults, and since IQ is 
closely related to memory test performance, a memory test score more 
than one standard deviation below the mean for young adults might 
represent a decline. However, the decline would only be recognised if 
intelligence started above "adequate intellectual function" and memory 
deteriorated to more than one standard deviation below the mean for 
young adults. People of lesser original intelligence could not therefore be 
described as suffering from the condition. Equally, those with an original 
level of intellectual functioning well above average, whose memory 
declined markedly with age but remained above the cutoff point for
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memory, would not be included by the diagnostic criteria. The 
suggestion to limit the IQ range to between 90 and 130 (Blackford and 
La Rue, 1989) may miss the groups potentially most distressed by an 
age-related decline in cognition.
2 .5 .3 .5  Performance on the MMSE
Performance on the MMSE should perhaps have been placed as an 
exclusion criterion, since it is presumably intended to aid exclusion of 
people who are suffering from dementia. Raising the cutoff from 24 to 
27, as has been suggested (Crook, 1989), would have removed 
approximately a quarter of AAMI cases (section 2.4 .10). Although this 
would give better sensitivity for the absence of dementia it would 
obviously reduce the specificity, excluding many more people with low 
intelligence, poor education and those from lower socio-economic class 
rather than just those with dementia (Brayne and Calloway, 1990; 
Christensen and Jorm, 1992).
2 .5 .4  EXAMINATION OF PROPOSED EXCLUSION CRITERIA
The exclusion criteria may be overly strict. For example people with 
diabetes or hypothyroidism are excluded even if adequately treated. Use 
of the Hamilton depression rating scale to aid exclusion of people with 
depression could be criticised since the scale was designed for assessing 
the severity of illness in a patient already diagnosed as being depressed, 
and Hamilton (1980) advised against its use as a diagnostic instrument. 
Because it loads heavily on somatic symptoms which are less reliable 
indicators of depression in the elderly, it tends not to be used in this age 
group.
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2.5 .5  AGE-CONSISTENT MEMORY IMPAIRMENT, AND LATE LIFE 
FORGETFULNESS
Blackford and La Rue (1989) suggested improvements to the 
classification of ageing-related memory change by adding two subtypes; 
Age-Consistent Memory Impairment (ACMI), and Late Life Forgetfulness 
(LLF). Their aim was not to target a group for treatment, but to reduce 
the heterogeneity of people defined by the AAMI criteria and so aid 
research into memory in the normal elderly population. They proposed 
that at least four different verbal and non-verbal memory tests should be 
used to avoid diagnosis on the basis of one idiosyncratic weakness. 
AAMI would be diagnosed when at least one test is 1 SD below the 
mean for young adults, ACMI when at least 75%  of tests were within 
plus or minus 1 SD for their age (therefore excluding people well above 
average for their age), and LLF when scoring at least 50%  of tests 
between 1 and 2 SD's below the mean for their age (consistently below 
average).
Smith et al (1991) presented prevalence data based on Blackford and La 
Rue's cognitive criteria from two groups of subjects; control subjects of a 
dementia study and volunteers. After exclusion for medical problems the 
prevalence rates for control subjects were 31%  AAMI but scoring more 
than 1 SD above age-appropriate means; 52%  AAMI and ACMI; 0%  
AAMI and LLF; 10% AAMI but performance too variable to be classified 
as ACMI or LLF. Prevalence rates for volunteers were 8%  AAMI but 
scoring more than 1 SD above age-appropriate means; 30%  AAMI and 
ACMI; 31%  AAMI and LLF; 19% AAMI but performance too variable to 
be classified as ACMI or LLF.
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The reason given for the marked difference in diagnosis of LLF was that 
different methods were employed for the exclusion of people with mild 
dementia. The condition described by LLF is considered to be closely 
related to BSF (Larrabee et a/, 1991), but many LLF subjects are likely to 
go on to show symptoms and signs of dementia.
2 .5 .6  AGEING-ASSOCIATED COGNITIVE DECLINE
A discussion document was recently published (Caine, 1993) from the 
Cognitive Disorders Work Group of the American Psychiatric Association 
Task Force on DSM-IV. Despite the many criticisms of both the concept 
of defining a disorder on what is essentially normal ageing and of the 
particular diagnostic criteria chosen, it seems likely that AAMI will appear 
in some form in the Z codes of DSM-IV, perhaps under the name 
"Ageing-Associated Cognitive Decline" (AACD). The Z code is the DSM- 
IV equivalent to the V codes of DSM lll-R; intended to include conditions 
not caused by mental disorder that are a focus of attention or treatment. 
AACD would be the lowest in a hierarchy of AACD, mild cognitive 
disorder and dementia.
The criteria suggested in Caine's article were for AACD to include 
reported cognitive decline, absence of overall functional decrement and 
test scores that put a person in the normal range of age- and education- 
matched peers. Mild cognitive impairment would include those with a 
history of intellectual decline, interference with higher order tasks, and 
one or more impaired cognitive parameters which were relatively mild 
and not functionally disabling enough to be considered dementia.
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The paper from the Cognitive Disorders Work Group (Caine, 1993) also 
stated that AACD would provide a descriptive label for those 
individuals who might benefit from memory/cognitive enhancement 
through behavioural or (in the future) pharmacological intervention". 
Clearly pharmacological treatment for cognitive symptoms of normal 
ageing is still on the agenda in America.
The practicalities of distinguishing AACD, mild cognitive disorder and 
mild dementia from each other and from normal ageing without cognitive 
decline are far from clear. One suspects that this will be impossible for 
research psychologists, let alone physicians, and that diagnosis and 
management decisions will be increasingly based on self-reported 
memory loss. It is therefore important to understand as much as possible 
about the presentation of memory complaint to doctors. A self-referral 
memory clinic described in Chapter 3 already attracts people who are 
distressed at a change in memory. Therefore this was thought to be an 
ideal setting to examine factors associated with the presentation of 
memory complaint in the absence of dementia. Chapters 3, 4  and 5 
describe three related projects based in the self-referral memory clinic 
that were designed to explore these issues.
2.6 Summary
In this chapter a pilot study and prevalence study of AAMI were 
described. 18.5%  of people between the ages of 50 and 94 suffer from 
AAMI as defined in the original work group document (Crook et a/,
1986). However, prevalence rates would vary dramatically by minor 
alterations in the particular diagnostic criteria chosen, and this is of
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concern since there has been little work performed validating the 
diagnostic criteria as proposed. Indeed there are many criticisms of the 
individual criteria, which have been examined in some detail. Of 
particular concern was the use of memory complaint for diagnosis, and 
the failure to take into account a person's original ability. Despite these 
concerns, AAMI will probably appear in some form in DSM-IV and 
pressure for pharmacological treatment is then likely to follow. People 
concerned about an ageing related decline in memory are already 
presenting to doctors for advice and treatment. It is important therefore 




REVIEW OF THE FIRST 100 ATTENDERS AT A SELF-REFERRAL
MEMORY CLINIC
3.1 Introduction
In Chapter 2, it was demonstrated that in a medically fit community- 
residing population subjective memory complaint is only weakly 
correlated with objective memory test performance. Memory complaint 
is important however, because distress at perceived decline is the 
motivating factor in leading people to seek medical help. Memory 
complaint is also likely to be an important factor in affecting diagnosis 
and management decisions by physicians since objectively measuring 
decline is so difficult. This will be especially relevant if drugs are 
licensed for mild memory impairment. For a variety of reasons then, it is 
important to understand more about memory complaint and in particular 
about the presentation of memory complaint to doctors. One way that 
people with mild memory impairment already present to doctors for 
advice and treatment is through memory clinics.
3.1.1 MEMORY CLINICS
Several memory clinics have been described in the literature (Philpot and 
Levy, 1987; Van der Cammen et at, 1987; Bayer et a/, 1990) and offer 
in-depth multi-disciplinary investigation of people with possible dementia. 
The Research Institute for the Care of the Elderly in Bath (RICE) has been
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running a memory clinic on these lines for several years. Most referrals 
to such clinics come from general practitioners, though some accept self- 
referrers to the memory clinic either directly (Bayer et al, 1990; 
Derouesne et at, 1989), or after telephone screening (Philpot and Levy,
1987).
3 .1 .2  THE SELF-REFERRAL MEMORY CLINIC AT RICE
A self-referral memory clinic was set up in parallel with the GP-referral 
memory clinic at RICE in 1990 in order to improve detection and 
diagnosis of dementia, particularly in the early stages. The nurse running 
the clinic screens for significant cognitive impairment, and those 
identified can if necessary be referred on to the GP-referral memory clinic 
for more intensive investigation.
Advertisements are posted in health centres, libraries, post offices and 
sports centres, offering a brief assessment to people with memory 
problems who telephone for an appointment. Attenders are asked to 
complete a short questionnaire which includes demographic details, past 
and present medical history and current medication. The nurse performs 
memory tests as well as checking the pulse, blood pressure and urine 
with labstix urinalysis.
Tests of cognitive function include the Mini-Mental State Examination 
(MMSE) (Folstein et al, 1975) and the Associate Learning subtest of the 
Wechsler Memory Scale (WALT) (Wechsler and Stone, 1983). The 
MMSE and the WALT have been described in Chapter 2.
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Most attenders are given reassurance when scores on all the tests are 
normal, but they are informed that if their memory continues to trouble 
them, then they may re-attend. All self-referrals are later discussed with 
a doctor or senior nurse and appropriate action is decided upon. Results 
of the findings are sent to the patients' general practitioners with any 
recommendations that are made. The attender can be separately 
informed of the conclusions and recommendations if appropriate.
The clinic attracts many people who report distress as a result of memory 
decline and who request advice and treatment. It is therefore an ideal 
place to study self-presentation of people with memory complaint. This 
chapter describes the first 100 patients who attended the self-referral 
clinic, with predictors of outcome.
3 .2  Methods
Notes were reviewed for the first 100 patients who attended the self 
referral clinic, and this was done with the assistance of the nurse who 
ran the clinic. Data abstracted included clinical information, memory test 
results, route of referral and outcome. A diagnosis was sought for those 
patients that were followed up in the GP-referral memory clinic. 
Statistical tests used are described in the results section. P values 
quoted are based on a two-tailed test of significance. Exact p values are 
given unless very small in which case the sign "p <" will appear.
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3.3 Results
Ninety nine of the one hundred attenders completed the questionnaire, 
with one person refusing to give any personal details.
3.3.1 DEMOGRAPHIC DETAILS
72 attenders were female, and the group had a mean age of 70 years 
(SD 9, range 47-91). 58 were married, 21 were widowed and 9
divorced without remarrying, and 11 were single. 30 attenders were 
living alone.
3 .3 .2  HOW ATTENDERS HEARD OF THE CLINIC
Of those people for whom data was available (38), 9 were advised by 
their general practitioner to come to the clinic, 20 saw an advertisement, 
and the remainder heard about the clinic by word of mouth. Although 
officially a self-referral clinic, often the initiative for the referral comes 
from someone close who is concerned, and many attenders are brought. 
For the 91 people who could be coded for this, 25 were brought, mostly 
by immediate family members or more distant relatives and friends.
3 .3 .3  MEDICAL HISTORY
Just over half of attenders were on some form of regular medication 
(53); of these most were on one type. The commonest preparations 
were anti-hypertensives (8), non steroidal anti-inflammatory medications 
(9), laxatives (7) and antiplatelet compounds (8). One of this sample was 
receiving an anxiolytic, 5 were on hypnotic medications, and 3 were
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taking anti-depressants. Five reported a family history of Down's 
syndrome, and 18 a family history of dementia. 23 reported a past 
history of depression severe enough to require treatment and 34  
considered they had been under stress in the past year. A variety of 
other past illnesses were reported, the commonest being cancers (4) and 
cerebrovascular accidents (3).
3 .3 .4  COGNITIVE PROFILE OF ATTENDERS
Descriptive statistics for the MMSE and the WALT are shown in Table 1. 
All attenders performed the MMSE, but only 84 the WALT, generally due 
to inability because of poor cognitive function. Of these 84, 36 people 
satisfied the AAMI1 criteria (ie scored at least 24 on the MMSE and 
thirteen or less on the WALT), and 40 subjects achieved results above 
these scores on both tests.
Table 1
Descriptive statistics for cognitive test scores of attenders
Variable Mean SD Minimum Maximum Number
MMSE 26.1 5.7 2 30 100
WALT 13.2 4.3 5.5 21 84
3.3 .5 OUTCOME
At the end of their visit, 61 attenders were discharged, usually with the 
reassurance that their performance on the memory tests was
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satisfactory. 20 were referred directly to the GP-referral memory clinic, 
and a further 19 were asked to re-attend the self-referral memory clinic.
Of the 19 people asked to re-attend the self-referral clinic, 4  did not 
attend for the appointment. Of the remaining 15, 9 were discharged as 
there was no indication for further assessment, and 2 were referred to 
the GP-referral memory clinic. 4  were asked to re-attend the self-referral 
clinic for a third time.
Of the 22 people seen in the GP-referral memory clinic, 20 had an 
organic illness responsible for their memory impairment, and 15 of these 
had a clinical diagnosis of probable Alzheimer's disease. One person was 
felt to be suffering from stress and one from ageing-related changes.
3 .3 .6  PREDICTORS OF REFERRAL TO THE GP-REFERRAL 
MEMORY CLINIC AT THE FIRST VISIT
Patients were more likely to be referred on to the GP-referral memory 
clinic after the first visit if they were older or if they were brought to the 
clinic, and were less likely to if they had a past history of depression 
(Table 2). A trend was seen for subjects to be less likely to be referred 
to the clinic if they were divorced and had not remarried. There was no 
significant difference in reported family history of dementia and no 
difference in whether the subjects were living alone or not. Both 
cognitive tests were significantly related to referral to the GP-referral 
clinic, though this is to be expected since the test scores were the 
principal means of determining who was referred.
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Table 2
Predictors of referral to the GP-referral memory clinic and the self-referral 






Age 78.8(5.7) 67.7(8.6) t= 6.9 p<0.001A
Brought 
to clinic
15/20 10/71 Chi2= 29.1 p<0.00001
Past history 
depression
1 /2 0 22/79 Chi2= 4.7 p<0.05
Divorced 1 /2 0 19/79 Chi2= 3.6 p<0.1
MMSE 19.7(6.0) 27.7(4.4)
CM•VO1IIN p<0.0001B
WALT 8.3(2.6) 14.0(4.0) •1IIN p<0.0001B
A T-test
Mann-Whitney test
3 .4  Discussion
The majority of attenders came to the clinic concerned about their 
memory but were not found to be suffering from significant cognitive 
impairment and were not advised to attend the GP-referral memory clinic. 
At least 36%  satisfied the AAMI1 criteria on the MMSE and the WALT, 
whilst at least 40%  scored too well.
Subjects thought not to require further assessment were younger, more 
likely to self-present rather than be brought by a friend or relative, more 
often had a past history of depression and were possibly more likely to 
be divorced. This suggests that memory complaint in many self-referrers 
was less related to objective impairment, and perhaps more related to
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affective illness or personality associated with affective illness. Although 
a full psychiatric assessment was not made on these subjects, few were 
taking anti-depressants. One can assume therefore that if self-referrers 
were suffering from depressive illness, it was undiagnosed.
It was interesting to note that a quarter of all self-referrers had been 
advised to attend by their general practitioners. This suggests that there 
may be cases where doctors do not feel a full assessment is necessary at 
the GP-referral memory clinic, but that reassurance is required.
3.4.1 SUPPORTING EVIDENCE FOR THE ROLE OF AFFECTIVE AND 
PERSONALITY FACTORS IN SELF-REFERRERS
Two studies from memory clinics which accept self-referrals give 
supporting evidence of affective and personality factors as being 
important in presentation (Philpot and Levy, 1987; Derouesne et al, 
1989).
In a large group of subjects self-referring to a memory clinic in Paris, of 
those able to complete self-report questionnaires and not receiving 
treatment for psychiatric illness, one sixth were found to be suffering 
from functional psychiatric illness (Derouesne et al, 1989).
In the memory clinic described by Philpot and Levy (1987) a quarter of 
attenders were found to have no evidence of cognitive impairment, and 
often these people had a family history of dementia, possibly therefore 
having heightened fear of the disease. Family history of dementia was 
not related to normal cognition in the present study, though it may be 
that the screening process referred to by Philpot and Levy preferentially
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selects people with a positive family history. Of the patients they 
described, a half had dementia and around one tenth were found to be 
suffering from depression.
It would appear that affective symptoms may be very common in people 
presenting to a self-referral memory clinic with memory complaint but no 
objective decline. The link between memory complaint and depressed 
mood was noted in Chapter 2. Depression can cause objective and 
subjective memory impairment, and may affect medical help seeking 
behaviour. Therefore, a prospective study was initiated to investigate 
the possible role of depression in the presentation of memory complaint. 
This study is described in Chapter 4.
3 .6  Summary
In this chapter, a retrospective study was described in which case notes 
were reviewed for the first 100 attenders at a self-referral memory clinic. 
The majority of attenders were not felt to be suffering from significant 
memory impairment and were discharged. At least 36%  satisfied the 
AAMI1 criteria on the MMSE and the WALT, but at least 40%  scored too 
well to be included by the criteria. Psychosocial factors and particularly 
depression may be important in the self-presentation of memory 
complaint in the absence of significant impairment.
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CHAPTER 4
SELF-REPORTED MEMORY LOSS, MEMORY PERFORMANCE AND 
DEPRESSIVE SYMPTOMS IN ATTENDERS AT A GP-REFERRAL AND A 
SELF-REFERRAL MEMORY CLINIC
4.1 Introduction
Diagnosis of AAMI relies heavily on self-report of memory loss, despite 
evidence demonstrated in Chapter 2 that memory complaint has little 
relationship to memory test performance and is more closely related to 
affective symptoms. In previous work memory complaint has been 
shown to be more closely related to depression in both depressed and 
normal community dwelling adults (Popkin et al, 1982; O'Connor et al, 
1990; Bolla et al, 1991), and in those attending a memory clinic 
(Derouesne et al, 1989).
The first 100 attenders at a self-referral memory clinic were described in 
Chapter 3. Many people who attend are distressed as a result of age- 
related memory decline, but most are discharged without indication for 
further assessment. Psychosocial factors were thought to be important 
in their presentation particularly because of their lack of significant 
memory impairment and the frequent history of depression.
Depressive disorders are well known to affect both subjective and 
objective memory performance (Larazus & Folkman, 1984; Strack et al, 
1985) but even sub-syndromal depression may affect a person's
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perception of their own performance (Derouesne et al 1989; Bolla et al, 
1991). Memory complaint in people treated for depression is reduced as 
mood lifts (Popkin et al, 1982; Plotkin et al, 1985).
AAMI is likely to appear in some form in DSM-IV (Cainef 1993), and 
pharmacological treatment trials have already been reported (Crook et al, 
1991; McEntee et al, 1991). It is therefore important to assess the 
significance of memory complaint in people presenting to doctors with 
mild or non-detectable memory impairment.
The current study compares subjective reports of memory decline and 
depressive symptomatology with objective measures of cognitive 
performance in people presenting to the self-referral clinic. Patients 
attending the GP-referral clinic and age- and sex-matched non-presenting 
community controls are used for comparison. It was hypothesized that 
the presentation of memory complaint to the self-referral clinic would be 
more closely related to depressed mood than to memory performance.
4 .2  Methods
All psychometric measures used in the present study have been 
described in Chapter 2.
Consecutive first time attenders presenting with memory dysfunction at 
the self-referral and the GP-referral memory clinics between February 
1992 and October 1992 were approached and asked to take part in a 
study examining the relationship between memory and mood. The study 
was explained and a written consent obtained (see Appendix 10).
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4 .2 .1  QUESTIONNAIRE DETAILS
Study subjects (or carers where appropriate) were questioned regarding a 
past history of depression that had received treatment. A memory 
complaint questionnaire was then completed, which was based on the 
MACQ (Larrabee et at, 1992) with the distress scale added (see Chapter 
2). Subjects then completed the Geriatric Depression Scale (GDS) 
(Yesavage & Brink, 1983).
4 .2 .2  INTERVIEW DETAILS
All subjects performed the Mini-Mental State Examination (MMSE) 
(Folstein et al, 1975) and the self-referral clinic subjects also completed 
the Associate Learning subtest of the Wechsler Memory Scale (WALT) 
(Wechsler & Stone, 1983). For practical reasons the cognitive testing for 
a number of subjects had to be carried out by a nurse involved in running 
the memory clinics. Inter-rater reliability was not formally assessed, but 
both raters underwent the same training, and discussed grey areas in 
administration and scoring to ensure consistency.
Since the GDS has not been validated for people scoring below 16 on the 
MMSE, this cutoff was used for exclusion from the study. Age- and sex- 
matched randomised community controls for the two groups were 
chosen blind from the prevalence study subjects described in Chapter 2 
and their scores on the various measures obtained. 71%  of the 
contactable prevalence study population were eligible as controls by 
scoring over 15 on the MMSE and having datasets that were complete 
for the purposes of the present study.
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4 .2 .3  ANALYSIS
The various statistical procedures used are described in the results 
section. A level of p < 0 .0 5  was set for statistical significance and all p 
values quoted are based on a two tailed test of significance.
4 .3  Results
All of the memory clinic attenders (55/55) agreed to participate. Four 
subjects from the GP-referral clinic and two from the self-referral clinic 
were excluded because of low MMSE scores. This left 20 subjects from 
the GP-referral clinic and 29 from the self-referral clinic. 49 control 
subjects were identified and a close age match was achieved (mean age 
difference 0.01 years SD 0.57).
4.3.1 COMPARISON OF GP-REFERRED AND SELF-REFERRED PATIENTS
The subjects in the self-referral clinic were younger than the GP-referred 
patients (Table 1). 29 women and 20 men were seen, with a non
significant trend for a greater proportion of women to attend the self­
referral clinic. The mean MMSE score of GP-referred patients was lower 
than that of self-referred patients after controlling for age using multiple 
regression. Only one of the self-referred patients included scored less 
than 24 on the MMSE. There was no significant difference in reported 
memory decline, distress as a result of this decline, or in depression 
score between the groups.
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Table 1









Mean (SD) 73.7 (8.9) 66.0 (7.6)
t=3.24A
p<0.01


































p  Multiple regression 
^ Mann Whitney
Self-referrers were more likely to report a past history of depression 
requiring treatment, but since this was sex related (with depression F:M 
13:3, without past depression F:M 15:18 Chi = ^ 5 .64 p < 0 .0 5 ), multiple 
regression analysis was performed to control for sex. There was no 
significant difference in past history of depression between the self­
referral and the GP-referral subjects after controlling for sex (T = 1.86).
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4 .3 .2  COMPARISON OF GP-REFERRED PATIENTS W ITH AGE- AND
SEX-MATCHED CONTROLS
The GP-referred patients had a lower mean MMSE than their controls 
(Table 2). Although the GP-referred patients did not report any more 
decline in memory, they were more distressed by the changes. There 
was no significant difference in reported depressive symptoms in the 
referred patients, and no difference between the GP-referred patients and 
their controls in the reporting of a past history of depression.
Table 2










Mean (SD) 24.3 (4.1) 27.6 (1.6)
z = 2 . 6 6 a
p<0.01
MACQ 















3/20 1 /2 0
Chi2=l.11 
NS
A Wilcoxon matched-pairs signed-ranks test
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4 .3 .3  COMPARISON OF SELF-REFERRED PATIENTS WITH AGE- AND
SEX-MATCHED CONTROLS
There was no difference between the self-referred patients and their 
controls in either of the cognitive tests used (Table 3). However, the self 
referrers reported a greater decline in their memory, were more 
distressed by this, and had higher levels of reported depressive 
symptomatology. They were more likely to report a history of depression 
requiring treatment.
Table 3










Mean (SD) 28.3 (2.2) 28.3 (1.7)
z = 0 . 3 5 A
NS
WALT 








Mean (SD) 3.6 (1.1) 1.7 (0.9)
z = 4 . 2 9 A 
p<0.0001
GDS 
Mean (SD) 11.1 (5.0) 6.0 (3.7)









A Wilcoxon matched-pairs signed-ranks test
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4 .3 .4  PREDICTORS OF ATTENDANCE AT THE SELF-REFERRAL MEMORY 
CLINIC AMONGST SELF-REFERRERS AND AGE- AND SEX- 
MATCHED COMMUNITY CONTROLS
In order to examine which factors most accurately predicted presentation 
of memory complaint to the self-referral clinic, stepwise multiple 
regression analysis was performed on the self-referrers and their controls, 
with MACQ score as the dependent variable, and pin and pout values set 
at 0.05 and 0 .10  respectively (see Chapter 2, Section 2 .4 .12 .6). 
Independent variables were past history of depression and scores on the 
MMSE, WALT, GDS, MACQ and DISTRESS scale.
Table 4
Predictors of attendance at the self-referral memory clinic amongst self- 




B (SE) BetaA T Sig T
Distress .24 (.04) .63 6.7 p<0.0001
Past history .27 (.11) .24 2.5 p<0.05
of depression
(Constant) -.19 (.10) -1.8 NS
Variables not Beta inB T Sig T
in regression
equation
AGE .12 1.3 NS
MMTOTAL -.07 - . 8 NS
WALTTOT -.05 -.5 NS
GDSTOT .11 .9 NS
MACQ .02 .2 NS
^Beta = regression coefficient
BBeta in = regression coefficient if variable were 
entered next into equation
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The only two variables included in the regression equation were the 
DISTRESS scale and past history of depression (Table 4). These jointly 
accounted for 53% of the variance.
4 .4  Discussion
4.4.1 RESULTS FROM THIS STUDY
In this study, patients self-referring to a memory clinic had cognitive test 
performance similar to a community control sample, but reported a 
greater decline in memory and were more distressed by this. They 
scored higher on a self-administered depression inventory and were more 
likely to report a past history of depression requiring treatment. The GP- 
referral group were older, had lower MMSE scores and had intermediate 
scores on memory complaint and depression questionnaires. Amongst 
the group of self-referrers and their controls, two variables in a 
regression equation predicted attendance at the self-referral clinic:- 
distress as a result of perceived memory decline and past history of 
depression requiring treatment.
Most of the self-referrers are seen by a nurse and are not routinely 
followed up. It is therefore not possible to determine whether some of 
the self-referrers were suffering from depression, though this would seem 
likely given the high mean scores on the GDS, and would agree with the 
high levels of depression found in memory clinics which accept self- 
referrers (Philpot and Levy, 1987; Derouesne et al, 1989). Three of the 
patients with high GDS scores were in fact assessed and were felt to be
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suffering from personality disorders and not depressive illness. This puts 
doubt on the 100% specificity for depression reported for a score of 14 
or above on the GDS (Brink et al, 1982). Some self-referrers may also 
have been in the early stages of dementia. However, the high MMSE 
scores of the group, and the reported small proportion of people with 
memory complaint but no objective impairment developing dementia over 
three years (Reisberg et al, 1986; O'Brien et al, 1992; Flicker et al, 
1993), suggests that few such cases were present in this sample.
4 .4 .2  MEMORY COMPLAINT IN PEOPLE WITH DEMENTIA
The patients referred to the memory clinic by their GP had generally been 
sent because of a suspicion of dementia, and it is not surprising that on 
average they had lower MMSE scores. The finding that these patients 
did not report a significantly greater decline in memory than either of the 
other groups is in keeping with most previous work (Kahn et al, 1975; 
McGlone and Oppenheimer, 1990; Feehan et al, 1991), though not all 
(Grut et al, 1993) and suggests denial or lack of insight that is common 
in patients with dementia, especially in later stages (O'Connor et at, 
1990).
4 .4 .3  POSSIBILITY OF GENUINE DECLINE IN SELF-REFERRERS
Unfortunately, no measure of previous memory function was available, 
and no tests were used to estimate original IQ for comparison with 
current memory performance which may have improved the validity of 
memory complaint (see Chapter 2). It is therefore not possible to 
determine whether people who complained of memory loss and 
depressive symptoms had experienced more or less decline than average.
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It may be that the self-referral group were originally very high performers, 
they had genuinely declined more than their controls and were distressed 
by this.
However, the fact that there was little difference in mean cognitive test 
performance between the self-referral group and age- and sex-matched 
community controls suggests that on average the self-referrers had not 
had any greater deterioration. This, with the high scores on the GDS and 
the increased frequency of past depression, suggests that affective state 
and possibly personality are likely to be more important than cognitive 
factors in the presentation of memory complaint in many of the self- 
referrers.
On the basis of this study's findings, a further study was designed to 
look at these issues of personality, affect and intelligence in the 
presentation of complaints of ageing-related memory decline. This study 
is described in Chapter 5.
4 .5  Summary
In this chapter a study was described which compared reports of 
memory loss, memory performance and depressive symptoms in 
attenders at a GP-referral and a self-referral memory clinic, with age- and 
sex-matched community controls. The GP-referred patients were older, 
had lower MMSE scores and had levels of memory complaint and 
depression between the control and self-referred subjects. The self- 
referrers had cognitive test performance similar to community controls 
but complained more of memory loss, were more depressed and more 
frequently reported a past history of treated depression.
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Self-presentation of memory complaint appears to be more closely related 




MEMORY COMPLAINT IN ATTENDERS AT A SELF-REFERRAL MEMORY 
CLINIC: THE ROLE OF COGNITIVE FACTORS, AFFECTIVE SYMPTOMS
AND PERSONALITY.
5.1 Introduction
In chapter 2 it was demonstrated that in the community, self-reported 
memory decline and distress experienced as a result of this perceived 
decline are only weakly correlated with objective memory performance. 
This was in keeping with previous findings, though the relationship was 
strengthened when a measure of pre-existing IQ was included (the NART) 
to improve the estimate of objective decline. Memory complaint was 
more closely related to affective symptomatology, however. Memory 
complaint is an important aspect of diagnosis in AAMI (Crook et al, 
1986), and will also affect a person's decision whether to seek medical 
intervention and a doctor's decision on how to manage them.
In Chapter 4 the role of depression in the presentation of memory 
complaint was examined more closely, with a prospective study 
assessing depressed mood and memory complaint in memory clinic 
attenders. Self-referrers were found to have memory test performance 
similar to age- and sex-matched controls, but had higher reported 
decline, distress as a result of this decline and higher depression rating 
scores. They were more likely to report a past history of depression. 
Some patients may have been suffering from mild dementia and some 
from depression, though three of the people with many depressive 
symptoms were in fact thought to be suffering from personality
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disorders. As no measure of previous function was available, it was not 
possible to assess whether the self-referrers had had more decline than 
average and were understandably upset by this.
The role of personality has not been investigated in this group of 
patients, but similar work on psychological factors in the presentation of 
unexplained physical symptoms suggests it may be important (Costa and 
McCrae, 1987; Goldberg and Bridges, 1988). Of particular relevance is 
the personality trait described by the terms trait anxiety, neuroticism and 
negative affectivity (Jorm, 1989). The Spielberger State-Trait Anxiety 
Inventory (Spielberger et al, 1983) is the most commonly used measure 
of trait anxiety and has been validated for use in elderly people 
(Patterson et al, 1980). It is more fully described in Chapter 2.
The study described in this chapter was designed to examine some of the 
issues raised by the previous study in Chapter 4, and in particular the 
role of pre-existing original IQ and trait anxiety in the presentation of 
memory complaint. It was hypothesized that the presentation of memory 
complaint in people with mild cognitive impairment would be more 
closely related to measures of depression and trait anxiety than to 
objective memory performance or estimated decline.
5.2 Methods
Consecutive first time attenders over the age of fifty presenting with 
memory complaint to the self-referral memory clinic were approached and 
asked if they would be willing to participate in a research study looking 
at the interaction of memory problems and mood. The study was
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described and if agreeable, written consent was obtained. Recruitment 
took place from November 1992 until August 1993.
The methodology used was essentially the same as that used in 
Chapter 4. As before, a questionnaire assessed past history of treated 
depression, antidepressant medication, and memory complaint using the 
MACQ and the Distress scale. A shortened form of the Geriatric 
Depression Scale (GDSS) was used (possible score 0-15) which has been 
shown to be similarly valid and reliable as a screening device for 
depression (Sheikh and Yesavage, 1986). The Trait anxiety scale of the 
State-Trait Anxiety Inventory (STAI-T) was also incorporated into the 
questionnaire. The cognitive tests used included the MMSE and the 
WALT. The National Adult Reading Test (Nelson, 1982) was also 
administered as a measure of pre-existing IQ. The MACQ, DISTRESS 
scale, STAI-T, MMSE, WALT and NART are described in Chapter 2. For 
practical reasons a number of subjects had their cognitive testing 
performed by the nurse involved in running the clinic. Inter-rater 
reliability was not formally assessed, but both raters underwent the same 
training, and discussed grey areas in administration and scoring to ensure 
consistency.
In order to provide an estimate of current memory test performance 
relative to original level of functioning, a new variable WALT ZDIFF was 
calculated (WALT ZDIFF = NART z score - WALT z score) (see Chapter 
2). Subjects were excluded if they scored less than 24 on the MMSE in 
order to reduce the chance of including people suffering from mild 
dementia. Age- and sex-matched controls were selected blind from the 
randomised community sample seen as part of the AAMI prevalence 
study described in Chapter 2, and scores obtained from their records.
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Only controls with full relevant data and scoring above 23 on the MMSE 
were included.
The various statistical procedures used are described in the results 
section. A level of p < 0 .0 5  was set for statistical significance and all p 
values quoted are based on a two tailed test of significance.
5 .3  Results
In the time period specified, 30 new attenders were seen at the self­
referral memory clinic. All consented to take part. Six subjects were not 
included in subsequent analysis: three had MMSE scores less than 24, 
one had poor eyesight and a married couple attending together had their 
forms removed after they started arguing over their responses. The 
remaining 24 subjects (5 men, 19 women) had closely matched controls 
(mean age difference 0 .06  years, SD 0.44). Eight of the 24 controls 
were the same as in chapter 4. Although ideally, controls that had 
previously been used would have been excluded, this produced some 
pairs with unacceptably loose age-matching.
5.3.1 COMPARISON OF PSYCHOMETRIC VARIABLES BETWEEN SELF­
REFERRAL SUBJECTS AND CONTROLS
Self-referrers had a higher NART-estimated IQ (Table 1). MMSE scores 
were similar for both groups, but there was a non-significant trend 
(p <  0.1) for the self-referrers to have a higher WALT score. There was 
no significant difference in WALT ZDIFF between the groups. Self- 
referrers reported greater memory decline and were more distressed by
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this. Past history of depression was more common in self-referred 
subjects, and levels of current depression and trait anxiety were also 
higher. Only one of the subjects, a control, was taking an antidepressant 
at the time of interview. Overall, females were more likely to report a 
past history of depression (12/38 females vs 0 /10  males, Chi-square 
4.21 Fisher's Exact Test p < 0 .0 5 ).
Table 1









NARTIQ 117.5( 7.7) 110.5 (10.8) z - -2.09 p<0.05A
MMSE 28.7( 1 .6) 28.3 ( 1-6) z= -1.02 NSA
WALT 14.1( 3.6) 12 .2 ( 4.7) z= -1.83 NSA
WALT ZDIFF 0 .1( 1 .1) -0.1 ( 1.1) z= 1 .2 NSA
MACQ 29.2 ( 3.5) 24.3 ( 3.4) z= -3.45 p<0.001A
DISTRESS 3 .4 ( 1 .1) 1.5 ( 0.7) z= -3.98 p<0.001A
GDSS 4.4 ( 3.3) 2 .1 ( 1-8) z= -2.62 p<0.01A
STAI-T
Past
43.1 (11.7) 31.5 ( 8.5) z= -3.57 p<0.001A
history of 
depression
9/24 3/24 Chi2= 4.00 p<0.05
A Wilcoxon Matched-pairs Signed-ranks Test
5.3 .2 PREDICTORS OF ATTENDANCE AT THE SELF-REFERRAL 
MEMORY CLINIC
In order to examine which factors predicted presentation of memory 
complaint to the self-referral clinic most accurately, stepwise multiple
i l l
regression analysis was performed on the combined group of 48  
subjects, with pin and pout values set at 0.05 and 0 .10  respectively (see 
Chapter 4). Independent variables were age, past history of depression, 
NART estimated IQ, scores on the MMSE, WALT, GDSS, STAI-T, MACQ 
and Distress, as well as the WALT ZDIFF score. The only two variables 
entered in the regression equation were the Distress and WALT score 
(Table 2). These jointly accounted for 31%  of the variance (26% due to 
distress scale).
Table 2




B (SE) BetaA T Sig T
Distress .27 (.04) .72 7.2 p<0.0001
WALT .03 (.01) .22 2 .2 p<0.05
(Constant) -2.50(.10) -13.5 p<0.0001
Variables not Beta inB T Sig T
in regression
equation
AGE .04 -.3 NS
MMSE -.06 .4 NS
NARTIQ .06 -.5 NS
WALT ZDIFF .07 -.5 NS
PAST HIST DEP - .0 0 .0 NS
GDSS .12 -1.1 NS
STAI-T .17 -1.5 NS
MACQ .12 -0.8 NS
^Beta = regression coefficient 
Beta in = regression coefficient if variable were 
entered next into equation
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5.4 Discussion
In this study it was shown that self-referring subjects on average have 
higher pre-existing IQs than age- and sex-matched controls, with a trend 
for higher WALT scores and no evidence of greater decline in WALT 
score relative to pre-existing IQ. They report a greater decline and are 
more distressed by the perceived deterioration. Self-referrers more 
commonly report a past history of depression, and score higher on 
current measures of trait anxiety and depression. The major predictor of 
being an attender at the self-referral clinic produced by a regression 
equation was distress at a perceived decline in memory with the WALT 
score also contributing.
A better educational background and higher intelligence has previously 
been described in self-referrers to a memory clinic (Derouesne et al,
1989) and in non-demented attenders at a GP-referral memory clinic 
(O'Brien et al, 1992). This is in keeping with the view that people with 
high intelligence are likely to be most disturbed by ageing related memory 
decline and the most likely to seek help for it (Crook et al, 1986; 
Reisberg et al, 1988).
Although one community study of elderly people described self-reported 
memory decline as universal, less than a quarter of subjects felt the 
memory difficulties even a slight nuisance (Sunderland et al, 1986). 
People who find the changes more distressing and seek medical help may 
do so because of factors to do with intelligence, affective state or 
personality.
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Some self-referrers may report more depression and memory decline as 
part of a generalised increase of symptom reporting seen in people with 
more neurotic personality traits. Neuroticism is significantly related to 
most DSM lll-R personality disorders and may also be associated with a 
past history of depression in the elderly (Abrams, 1991).
5.4.1 BECK'S COGNITIVE THEORY OF DEPRESSION
Beck's cognitive approach to depression may give an additional 
understanding of these people (Beck, 1967). He believed that
dysfunctional assumptions laid down in childhood predispose a person to 
negative automatic thoughts and cognitive distortions which lead to the 
regarding of self, current experience and future negatively. These factors 
make a person vulnerable to depression. Previous studies have noted 
that non-demented attenders at a memory clinic are often concerned 
about the possibility of dementia (Philpot and Levy, 1987), and high 
levels of depression have been seen in the self-referrers described in this 
chapter and Chapter 4. Self-referrers view their own memory as poor, 
are particularly distressed by this (even though objectively their memory 
performance is no worse than their non-presenting peers) and more often 
report a history of depression severe enough to require treatment.
5 .4 .2  THE COMPARISON WITH UNEXPLAINED MEDICAL SYMPTOMS
A comparison can also be made between self-referrers' reports of 
memory decline and the phenomena of unexplained medical symptoms 
(Goldberg & Bridges, 1988). Self-reported poor general health is related 
to memory complaint in community residing elders (Cutler and Grams, 
1988). In a General Practice surgery, high levels of memory complaint
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could be predicted in people presenting with what the general 
practitioner felt were psychological or mixed psychological/somatic 
motives (Derouesne et al, 1993).
Somatosensory amplification is one way in which unexplained medical 
symptoms may arise. The term describes heightened awareness of, and 
concentration on, relatively weak sensations with cognitions that 
intensify them and make them more disturbing. Measures of 
amplification are correlated with depression and anxiety (Barsky et al
1990). Memory lapses are common in all age groups, and particularly in 
the later decades of life. Some people, for example those with high trait 
anxiety/neuroticism, may be more aware of them, attribute increased 
significance to their presence, and seek medical help for them. A 
psychological treatment based on a cognitive-behavioural model for 
functional somatic symptoms has been described (Sharpe et al, 1992) 
and it would be interesting to attempt a similar intervention in people 
with complaints of memory loss but no objective evidence of impairment.
Memory complaint may be a cause, a result, or independent of any 
impairment found. If drugs are licensed for treating cognitive impairment, 
the objective demonstration of decline, and then understanding the 
relationship of memory complaint to this decline, will be vital, to ensure 
the most appropriate pharmacological or psychological therapy is given.
5.5 Summary
In this Chapter, a study was described of cognitive and affective 
measures in non-dementing subjects self-referring to a memory clinic in
115
comparison with non-presenting age- and sex-matched community 
controls. The particular aims were to assess the role of pre-existing IQ 
and trait anxiety in the presentation of memory complaint. Self-referrers 
had a higher original IQ, but no evidence of greater decline despite 
having more memory complaint. Personality factors were demonstrated 
to be important alongside affective symptoms in the presentation of 
memory complaint in non-demented subjects, and several possible ways 




6.1 The reasons why this research project was necessary
This research project was planned some 5 years after the NIMH work 
group had published the proposed diagnostic criteria for AAMI. 
Responses to the concept and criteria proposed had been published, and 
much in these was critical. No accurate prevalence data were available 
and at the time of submission of this thesis no major international journal 
has published a prevalence study of AAMI using the original diagnostic 
criteria. It was and still is of concern, therefore, that this newly defined 
disorder with apparently little proven scientific validity is likely to appear 
shortly in DSM IV, and it is surprising that treatment trials were 
commenced so soon. The present study was therefore necessary to 
provide a better idea of how common the disorder is in the community, 
while at the same time allowing examination of the diagnostic criteria 
chosen.
6 .2  A summary of the main conclusions of the thesis
The main study in this thesis (Chapter 2) provides what appear to be 
reliable estimates of prevalence of AAMI for various age groups. 
Prevalence rates for the total population and for the over 50s were 
estimated to be 5.8%  and 18.5% respectively. These rates are less than 
other researchers had estimated, and this is likely to be due to the more
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rigorous methodology applied in the present study. In particular, an 
objective measure of memory complaint was used which was designed 
for assessing significant reported decline in people with AAMI, and the 
psychiatric and medical assessment of people with possible AAMI was 
more extensive. Prevalence rates were shown to be dramatically 
affected by minor alterations to individual criteria, however. This turned 
the focus to the diagnostic criteria themselves. A number of the 
inclusion and exclusion criteria were examined and weaknesses and 
inconsistencies demonstrated. Of particular concern was the use of 
memory complaint as a diagnostic criterion and the lack of attention paid 
to a person's educational and intellectual background.
Memory complaint was shown to be poorly correlated with memory test 
performance, even though it is an essential part of diagnosis in the 
original AAMI criteria and is also likely to be important in DSM IV. 
Memory complaint is likely to be the driving factor in motivating people 
to seek medical attention if, as has been suggested, drugs were licensed 
for the treatment of AAMI. Since the psychometric complexities of 
demonstrating memory decline will elude most practising physicians, 
memory complaint is likely to be relied upon to make a diagnosis and will 
influence management decisions by clinicians.
It was fortunate that a self-referral memory clinic was located at the 
institute in which the author was based, since this provided a ready­
made opportunity to study self-presentation of people with memory 
complaint. Three studies carried out in parallel with the prevalence study 
investigated factors involved in the presentation of memory complaint by 
people with mild or non-detectable memory impairment. These 
highlighted the role of psychosocial factors in the presentation of
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memory complaint and most particularly high intelligence, depression and 
trait anxiety. Actual memory decline or impairment was thought to be of 
less significance.
6 .3  The purpose of the diagnostic criteria for AAMI
When dissecting the diagnostic criteria and critically examining the 
psychometric properties of individual tests, it is possible to lose sight of 
the purpose of the criteria. This is a particular problem because AAMI is 
such a nebulous concept and the original paper by the NIMH work group 
had little explanation of the reasons for the specific criteria chosen, or 
even what population they were intending to define. This confusion has 
been noted by others (Bamford and Caine, 1988; Allain et al, 1990; 
Barker and Jones, 1993).
The stated purpose of defining AAMI was to aid research and scientific 
communication, to note the distress experienced by some elderly people 
and to recognise the importance of developing treatments. The 
justification for inclusion in DSM IV is to reassure elderly people that they 
are not suffering from Alzheimer's disease and to identify people who 
might benefit from behavioural or pharmacological intervention.
6 .4  The argument for drug treatment of AAMI
The argument for treatment of AAMI is that some people probably have 
ageing-related reductions in cognitive test performance of up to 50%  of 
their original function (Crook and Ferris, 1992). If this degree of 
impairment were seen in the young, then there would probably be little
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argument over the use of drug treatments for these people. Elderly 
people with "normal" failing eyesight are given glasses to improve their 
visual acuity and this practice is not challenged. If people are distressed 
by a decline in memory, would it be ethical to deny them access to 
pharmacological treatment if this were shown to be the treatment which 
brought about the greatest improvement?
The real stumbling blocks in getting AAMI accepted by doctors are firstly 
the concept of "diagnosis" of normality and then the suggestion of using 
pharmacological treatment for this condition.
6 .5  Criticisms of the concept of AAMI and arguments against its 
pharmacological treatment
6.5.1 GENERAL PRINCIPLES OF DIAGNOSIS AND TREATMENT
Doctors diagnose and treat diseases; in the medical world the term 
"diagnosis" is inextricably linked to disease. The definition of disease is 
not simple, though. A disease may be defined at a number of levels: 
purely as a syndrome of concurrent symptoms and signs, functionally, 
anatomically, or aetiologically. It is first recognised syndromally 
(Campbell, 1977): then, as knowledge progresses, the defining process 
moves up a level. Implicit in its definition though, is a distinction from 
health.
Although diagnosis and treatment of AAMI is frequently mentioned in the 
work group's paper (Crook et al, 1986), it is never referred to as a 
disease, and psychometric scores distinguishing AAMI from "pathologic"
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memory loss have since been published (Crook, 1989), supporting the 
impression that AAMI was not intended to describe pathology.
In some medical conditions, such as diabetes and hypertension, where 
the clinical signs are part of a continuum in the general population, often 
the oniy basis for diagnosis and treatment is the presence of a significant 
deviation from the population norm, where this has been shown to be 
associated with increased risk of morbidity. The extreme case is easily 
identified, but in cases of lesser severity there is greater overlap with 
normality, and the balance between probable treatment success and the 
risk of deleterious side effects is finer.
In certain conditions, doctors already intervene in distressing changes 
that may be seen as part of normal ageing: maintenance of function is a 
well recognized and important goal of geriatric medicine. Diagnosis 
precedes treatment, but is not the only determining factor in the decision 
to treat: for example, the usage of oral hypoglycaemic drugs in elderly 
people with diabetes will vary with a doctor's concept of what blood 
sugar level constitutes disease in this age group, as well as what the 
most appropriate therapeutic target should be (e.g. lowering the blood 
sugar to a predetermined level or purely symptomatic treatment). It will 
also vary with the patients' demands in terms of their expressed distress 
and desire for specific treatments.
The doctor's role is clearly not just to treat a diagnosis, but is directed at 
relieving distress and promoting health. The controversy over the 
suggestion to treat AAMI comes not from the idea of helping people who 
are distressed by an ageing-related deterioration in function, but from the 
proposed use of drugs for this.
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6 .5 .2  TREATMENT ISSUES IN AAMI
There has been a little work examining the effectiveness of psychological 
treatments for ageing-related memory decline and it appears encouraging. 
Willis (1989) describes a study where the level of performance of 40%  of 
elderly subjects could be shown to return to, or to improve upon, their 
own performance 14 years previously on certain cognitive tasks. Willis 
describes several other studies where improvements in memory after 
psychological treatment are in the order of 0.5 - 1.0 standard deviations 
compared with pretreatment levels. Larrabee et a/ (1992) report a study 
in which training to improve memory for names and faces raised test 
scores from baseline by a factor of 73-111% . This improvement was 
shown to be maintained at six months follow up. These results are 
certainly better than the early drug treatment trials so far described 
(Crook and Lakin, 1991; Crook et al, 1991; McEntee et a/, 1991).
There are several issues that need to be taken into account in explaining 
the concerns specifically related to pharmacological treatment.
Firstly, before a treatment is to be considered, there has to be a 
consensus that an impairment or dysfunction exists which can be defined 
to form a relatively homogeneous patient population. This has not yet 
been achieved for AAMI for a variety of reasons discussed in Chapter 2. 
Since the criteria by design make no attempt to differentiate AAMI from 
normal ageing the reluctance to intervene in normality or nature has to be 
overcome. Leber (1992) of the USA Food and Drugs Administration, 
though speaking from a personal viewpoint, felt that of the hurdles that 
any drug would have to overcome to be licensed for treating AAMI 
"None would be more important than the public's negative predisposition
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toward treatments that can be viewed as intended to enhance the 
performance of those presumed to be in a disease-free state". Anti­
depressants are not used for people who are sad but for people who are 
depressed. Indeed, artificially raising mood with chemical euphoriants is 
considered as drug abuse.
If a group of people with ageing-related memory decline could be 
satisfactorily identified, and a drug with minimal side effects was 
identified that significantly improved memory, what should the target be 
for treatment? Should elderly people be treated to a norm appropriate for 
their age, appropriate for young adults, or should the aim be to reverse 
any deterioration up to the level of the person's original function? How  
could one know when that level had been reached? In theory, one could 
even attempt to maximize a person's performance to a level greater than 
their original function although this might be dangerous and runs contrary 
to medical opinion. This has been seen in the use of anabolic steroids by 
athletes.
6 .5 .3  SMART DRUGS
There is a clear parallel here with the use of so called "smart" drugs to 
improve cognition. Crook (1993) insists that proposing treatment for 
AAMI does not provide a rationale for giving smart drugs to young 
healthy people since they have no neurochemical deficit or behavioural 
problems. One could argue that anyone requesting smart drugs would by 
definition be displaying behavioural problems! The argument is flawed for 
other reasons though, since if the disorder to be defined is an ageing- 
related decline, theoretically people in their mid twenties could be eligible 
for treatment.
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Animal studies with one putative memory enhancer showed improved 
learning in both old and young rodents (Barnes et al, 1990), and this may 
suggest that treatment response is not limited to neurochemistry which 
has been altered by an ageing process. In humans, unless a memory- 
disordered group was defined very carefully, any improvement seen in a 
treatment trial might be due to a beneficial effect in people with naturally 
lower cognitive abilities rather than in those with an acquired deficit.
Allain et al (1990) describe the potential uses of cognitive enhancers to 
improve normal cognition in high demand situations such as examinations 
or for people requiring particular vigilance. There is clearly a great risk of 
abuse and misuse of such drugs. For this reason licensing of drugs for 
AAMI should be considered with extreme caution. Rosen (1990) raises a 
different concern; that if drugs were available for treating ageing-related 
cognitive impairment, people in their 50s and 60s might come under 
pressure at work to take medication to improve their performance.
With the many criticisms that have been described, it would appear that 
proposing diagnostic criteria for AAMI and suggesting pharmacological 
treatment for the disorder is out of step with and distant from the needs 
of clinicians in elderly care.
6 .6  The suspicion that the motivation for defining AAMI is 
coming from pharmaceutical company pressure
The NIMH paper contains a section regarding treatment of AAMI which 
contains a rather curious argument along the following lines:- 
pharmacological treatment trials in diseased humans (i.e. Alzheimer's 
disease) have not produced significant beneficial results despite
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promising results from animal studies, because the animals used were 
aged but normal. Therefore trials ought to be conducted on normal aged 
humans. The impression this gives is that a condition is being developed 
to fit a treatment rather than the other way around.
The emphasis on pharmacological treatment of AAMI and the proposal to 
focus clinical trials on people suffering from the disorder, combined with 
the lack of explanation for the diagnostic criteria chosen, has encouraged 
the suggestion that the criteria are most concerned with identifying 
healthy subjects for inclusion into drug trials for age-related cognitive 
impairments (Bamford and Caine, 1988). There is suspicion that the 
need for defining the disorder was at least partly influenced by needs of 
drug companies for a market place for compounds that have undergone 
extensive and expensive testing in Alzheimer's disease without 
significant benefit (Dawe et al, 1993; Hindmarch, 1993).
It is perhaps significant that such a high proportion of the work group 
were affiliated to various pharmaceutical companies and it is unfortunate 
that several of the authors of the working group's paper are associated 
with commercial memory clinics and the development of computerized 
cognitive testing systems for clinical trials into AAMI.
6.7 Future research
6.7.1 AAMI: A RESEARCH DIAGNOSIS OR A CLINICAL DIAGNOSIS?
The final pages of a thesis would normally be expected to provide 
suggestions for future research. This task has proved especially
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demanding because of the nature of the disorder studied. The concept 
of AAMI is one with few clear boundaries in either medical or 
philosophical terms, despite the apparent clarity portrayed by the detailed 
list of inclusion and exclusion criteria produced for its diagnosis.
It is unciear whether the diagnostic criteria were intended to define a 
population of elderly people purely for research purposes or for use in 
clinical diagnosis of patients. Thus it is hard to suggest how they should 
be developed.
If they were intended for research purposes only, the aim should be to 
develop the diagnostic criteria further, but the risk is that the research 
methodology that would be necessary becomes so demanding as to be 
impracticable. Blackford and La Rue's work (1989) (see chapter 2), 
though of great merit in shifting the emphasis onto defining a disorder by 
comparison with age-matched peers, may be falling into this trap. They 
extended the one diagnosis of AAMI into three: AAMI, ACMI and LLF. 
A part of the process of diagnosis requires the use of at least 4  verbal 
and non-verbal memory tests to demonstrate a 1 and 2 standard 
deviation discrepancy from age-appropriate and young population norms. 
They did not feel they should recommend any cutoff scores on any 
particular tests however, because they believed the relevant cutoffs 
should vary for each population under study, having to be based on age-, 
education- and social class-matched data. The initial aim of proposing 
diagnostic criteria for AAMI in order to improve research and scientific 
communication seems to have been lost.
If the AAMI criteria were intended for clinical use, then there are many 
criticisms of the concept and the individual criteria which have already
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been discussed. If treatments became available, as the work group 
clearly intended, would it really be justifiable to "exclude" people from 
diagnosis and hence treatment, of whatever sort, because they also had 
a medical condition that could be associated with memory impairment? 
This would surely be like refusing to treat breathlessness caused by 
asthma in someone because they also had congestive cardiac failure. 
Therefore memory impairment which may be due to other medical causes 
would also have to be given a diagnostic label and be open to treatment. 
Once one pharmacological treatment for an ageing-related phenomenon 
was available, others would follow - perhaps growth hormone to restore 
a strong lean body (Anon, 1991). This would be likely to have wide 
ranging implications, not only in financial terms for an increasingly 
stretched National Health Service budget, but also in terms of society's 
values,
6 .7 .2  SUGGESTIONS FOR THE DEVELOPMENT OF AAMI
A number of suggestions to improve the diagnostic criteria and focus of 
AAMI have been presented in this thesis. These have arisen from the 
experience of interviewing healthy elderly people in their own homes, 
from interpretation of data that has been collected, and from reflecting 
on the many papers studied during the preparation of the thesis. 
Reference has been made to these during discussion of results. Broader 
issues of diagnosis and treatment have also been examined. They will be 
summarised here.
A proportion of people with AAMI are in the early stages of dementia, as 
yet undiagnosed (O'Neill et al, 1992®). The development of strategies to 
slow down or reverse the progression of Alzheimer's disease and other
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forms of dementia is of major importance and such strategies are likely to 
be most effective in early dementia. Early detection of dementia is 
therefore essential in its own right, but will also assist in the delineation 
of non-disease ageing-related cognitive changes.
Similarly, many people, particularly those who present to doctors, are 
likely to be suffering from depression or other affective psychiatric illness 
which could potentially be easily treatable. Improving detection and 
treatment of these disorders should therefore be part of a broader 
approach to managing people presenting with mild memory problems.
In order to demonstrate cognitive decline in elderly people, the most 
appropriate objective comparison for current performance is an 
individual's previous level of function. Although ideally this would be 
based on sequential cognitive tests starting in early adulthood, in practice 
this information is unlikely to be available. The recent introduction of 
health screening in General Practice may be a way in the future to obtain 
baseline data (Barker et al, 1992).
Research is required to describe how memory and cognitive performance 
changes with age in people with varying premorbid abilities; as part of 
this work it is hoped that the subjects seen in the studies described in 
this thesis will be followed up in the years to come. When this data is 
available, it will be possible to estimate whether, and how much, a 
person's abilities have decreased. It will also be possible to estimate 
how much a person's memory has declined in comparison with his or her 
peer group. The assessment necessary will include several age and IQ 
standardized memory tests.
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The decision to treat someone whose memory has deteriorated, whether 
by psychological or pharmacological means, will depend on a number of 
factors. These will include deciding how much deterioration represents a 
significant loss, the level of distress experienced, and the patient's 
wishes for treatment. Determining whether the distress is a cause or a 
result of the memory decline will need careful assessment.
I, like others (Blackford and Rue, 1989; Smith et al, 1991; O'Brien and 
Levy, 1992), am inclined to suggest that if treatments are available they 
should be focussed at the severe end of the spectrum of ageing-related 
changes, where there is greater chance of significant impairment and an 
increased likelihood that what is actually being seen is the early stage of 
a dementing process.
Finally, I am averse to the idea of pharmacological treatment being 
promoted for the alleviation of symptoms of ageing, as it diverts 
attention from understanding and accepting the inevitable facts of 
existence. It would be sad if, in the view of society, ageing came to be 
seen as a disease bringing a progressive deterioration in all faculties, to 
be feared and resisted at all costs, rather than as a natural process that 
brings many enriching experiences as life unfolds from birth to death.
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APPENDIX 1
Proposed diagnostic criteria for AAMI 
(from Crook et al, 1986)
1. Inclusion criteria
a. Males and females at least 50 years of age.
b. Complaints of memory loss reflected in such everyday problems
as difficulty remembering names of individuals following 
introduction, misplacing objects, difficulty remembering 
multiple items to be purchased or multiple tasks to be 
performed, problems remembering telephone numbers or zip 
codes, and difficulty recalling information quickly or 
following distraction. Onset of memory loss must be 
described as gradual, without sudden worsening in recent 
months.
c. Memory test performance that is at least 1 SD below the mean
established for young adults on a standardized test of 
secondary memory (recent memory) with adequate 
normative data. Examples of specific tests and appropriate 
cutoff scores are listed below, although other measures with 
adequate normative data are equally appropriate.
Test Cutoff score
Benton Visual Retention Test
(number correct, Administration A) 6 or less
(Benton, 1963)
Logical Memory subtest of the
Wechsler Memory Scale (WMS) 6 or less
(Wechsler and Stone, 1983)
Associate Learning subtest (WMS) 13 or less
d. Evidence of adequate intellectual function as determined by a
scaled score of at least 9 (raw score of at least 32) on the 
Vocabulary subtest of the Wechsler Adult Intelligence Scale 
(Wechsler, 1955).
e. Absence of dementia as determined by a score of 24 or higher
on the Mini-Mental State Examination (Folstein et al, 1975).
2. Exclusion criteria
a. Evidence of delirium, confusion, or other disturbances of 
consciousness.
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b. Any neurologic disorder that could produce cognitive
deterioration as determined by history, clinical neurological 
examination, and, if indicated, neuroradiologic examination. 
Such disorders include AD, Parkinson's disease, stroke, 
intracranial haemorrhage, local brain lesions including 
tumors, and normal pressure hydrocephalus.
c. History of any infective or inflammatory brain disease including
those of viral, fungal, or syphilitic aetiologies.
d. Evidence of significant cerebral vascular pathology as
determined by a Hachinski Ischaemia Score (Rosen et al, 
1980) of 4  or more, or by neuroradiologic examination.
e. History of repeated minor head injury (eg in boxing) or single
injury resulting in a period of unconsciousness for 1 hr or 
more.
f. Current psychiatric diagnosis according to DSM-III criteria
(American Psychiatric Association, 1980) of depression, 
mania, or any major psychiatric disorder.
g. Current diagnosis or history of alcoholism or drug dependence.
h. Evidence of depression as determined by a Hamilton Depression
Rating Scale (Hamilton, 1967) score of 13 or more.
i. Any medical disorder that could produce cognitive deterioration
including renal, respiratory, cardiac and hepatic disease; 
diabetes mellitus unless well controlled by diet or oral 
hypoglycaemics; endocrine, metabolic, or haematologic 
disturbances; and malignancy not in remission for more than 
2 years. Determination should be based on complete medical 
history, clinical examination (including electrocardiogram) 
and appropriate laboratory tests.
j. Use of any psychotropic drug or any other drug that may




Text of letter of introduction from General Practitioners





We are working in collaboration with Doctors from the Research Institute 
for the Care of the Elderly, St Martin's Hospital, who are looking at how 
memory changes with ageing. We would like to introduce Dr Barker who 
will be approaching you in the near future to see if you would be 
prepared to help, and enclose a letter from him. If you feel you do not 
want to take part, then it will not affect your treatment with us in any 
way. If you have any questions, please get in contact with Dr Barker 
directly who will be happy to deal with them.
Yours sincerely,
Dr David Carr Dr John Turner
Dr Christina Kennaway Dr Neil Snowise
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APPENDIX 3
Text of letter enclosed with letter from GP
Dear ,
The Doctors and Nurses at R.I.C.E. are involved in 
various projects investigating illness and helping to improve care for 
people of increasing age. It would help us greatly if we could understand 
more about the normal changes that occur in memory as we get older. I 
am therefore carrying out a community survey of people over the age of 
fifty who are registered with the Doctors at your Health Centre, and 
would be very grateful for your assistance.
If you agree to help, I would ask you to complete a short 
questionnaire into health and memory related issues, and would then like 
to meet to do some routine memory tests. This could be arranged at a 
time and a place convenient for you. In a minority of cases, further 
investigations may be suggested, but these would be voluntary and 
would be discussed with you.
You would of course be free to withdraw at any time, and any 
information given to me would be treated as confidential.
I will try to contact you personally within the next couple of weeks 
to see if you would be prepared to help, but if you have any questions or 
would like to discuss this further, please get in contact with me at the 
above address, or telephone number.





Text of letter confirming appointment
Dear ,
Thank you for agreeing to participate in the study assessing normal 
memory changes with increasing age. I confirm that we agreed to meet 
at on
at , and enclose the questionnaire on health and memory related
issues. I would be grateful if you could try to be as honest as possible, 
and for the questions which give you a choice of answers try to indicate 
which is closest to the correct answer for you. It would be useful if you 
could complete the questionnaire before I see you, but if you are 
uncertain how to answer any of the questions, I will try and assist when 
we meet. I would be happy to discuss the results with you later if you 
wish.





Text of front sheet of prevalence study questionnaire 
(rest of questionnaire was psychometric tests)
N A M E .........................................................
ADDRESS.......................................................
SEX  DATE OF BIRTH.
1. What has been your main lifetime occupation ?
2. At what age did you start school ?
3. At what age did you leave full time education ? 
YOUR PAST HEALTH
4. Have you ever suffered from any of the following ? 











Head injury for 
which you were 
hospitalized
High blood pressure
Are you on any regular medication ? yes I— • no 
If yes, could you please give details
APPENDIX 6 
Prevalence study consent form
A community prevalence study of memory impairments in a population of 
over fifty year-olds registered with a Bath Health Centre
CONSENT FORM
I f agree to take part in the above study which will
consist of completing a questionnaire and some memory tests. I 
understand that in the event of my having a problem with my memory, I 
may be advised to have further investigations. At any stage I may 
withdraw from the study should I choose to do so, without having to 
justify my decision.
Any information obtained will be considered confidential to the 
study, but my general Practitioner may be informed of health related 
issues, after discussion with me wherever practical. There would be no 






Text of interview used in prevalence study 
NAME............................................. ADDRESS
DATE OF BIRTH.................. TEL NO..............................
DATE G.P..................................
Scores- mac-q gds stai-s stai-t........
mmse..... nart (IQ) (nart-r IQ).......benton........
- log mem....wait....wvocab....(scaled score)....(IQ)....
i t * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
MARITAL STATUS....................  LIVE ALONE.................
1. W HAT HAS BEEN YOUR MAIN LIFETIME OCCUPATION ?
2. MAIN LIFETIME OCCUPATION OF PARTNER (IF FEMALE)
3. AT WHAT AGE DID YOU START SCHOOL ?
4. AT WHAT AGE DID YOU LEAVE FULL TIME EDUCATION ?
Significant past medical history
Alcohol - present units





Smoke - past - started stopped Average number / day 
- present





Focal neurological symptoms (15) Y__N
152
Presenting Memory Problems
Memory problems present years months




Stepwise progression with "patchy" 
deficit distribution early in the course
Only present during delirium ?
Seizures or gait disturbances 
very early in illness ?
Focal neurological signs early 
in course of illness




Dyspraxia, dysphasia, or agnosia present ?
Activities of Daily Living
Significant interference with work, 














Capacity For Independent Living Remains, with 
adequate personal hygiene and relatively 
intact judgement.
OR
Independent living is hazardous, and some degree of 
supervision is necessary.
OR
Activities of daily living are so impaired that 
continual supervision is required,
e.g. unable to maintain minimal 






For DSM lll-R "Major depressive episode"
A. At least 5 of following, >  = 2/52 duration, a change from prev 
function, including 1.or 2.
1. Depressed mood
2. Markedly diminished interest or pleasure
3. Siginificant weight loss or gain when not dieting
4. Insomnia or hypersomnia
5. Psychomotor retardation or agitation
6. Fatigue or loss of energy
7. Feelings of worthlessness or innappropriate guilt
8. Diminished ability to think or concentrate
9. Recurrent thoughts of death, suicidal thoughts or suicide attempt
B.1. No evidence of organic initiation
2. Not a normal bereavement reaction
C. Delusions or hallucinations only with prominent mood symptoms
D. Not superimposed on schizophrenia
Premorbid personality
Personality change (17) Y N




Disturbance of consciousness (18) Y N
Evidence of short term deficit (5 minutes) (19) Y N
Evidence long term deficit (20) Y__N
(yesterday/longer or facts of common knowledge)




Non organic mental disorder responsible for memory disorder.
(22) Y N
Support Services at Present 
CPN _
District Nurse __































Focai neurological signs (16) Y__N
BLOOD TESTS
FBC TFTs BIOCHEMISTRY VDRL B12/FOLATE
Evidence of signif cerebrovascular disease 
aetiologically related to disorder (23) Y__N
Specific causes of the dementia excluded by history, 
physical examination and laboratory tests (24) Y__N
Evidence of specific organic factor aetiologically 
related to the disorder (25) Y__N
Single, severe progressive cognitive deficit 
in absence of identifiable cause (26) Y__N
Clinical impression / Probable Diagnosis
Plan of Management/Recommendations
KEY FOR DIAGNOSIS (if in doubt consult original criteria)
DSM lll-R
Dementia - 19 +  20 +  (21 or 11 or 9 or 17) + 10 + 6 (No)
+ (25 or 22 (No))
Severity of dementia - Mild 12 Moderate 13 Severe 14
Alzheimer's disease - Dementia as above + 24 +  3 + 4
Multi infarct - Dementia as above + 5 +  15 + 16 +  23
NINCDS ADRDA Alzheimer's disease
Probable - Dementia as above + 1 + 4  + 18 (No) + 24
Probable unlikely- 2 or 7 or 8
Possible -(19 + 2 0 +  (21 or 11 or 9 or 17) + 1 0  +  6(No) + 24 (25 




1. Carcinoma of prostate diagnosed in past year. Severe head 
injury as a child.
2. CVA 3 years previously. Hachinski >  3.




6. Dizzy spells and falls ? cause.
7. Myeloma on intermittent chemotherapy regime, taking 
antidepressants.
8. Two head injuries when lost consciousness and once lost vision.
9. Taking anxiolytic.




13. Taking antidepressants for poor sleep.
14. CVA.
15. Was dependent on diazepam for 10 years.
16. Heavy alcohol consumption in past.
17. Lead poisoning in past and laft unable to walk. Diabetic. 
Myocardial infarction with loss of consciousness.
18. DSM lll-R major depression. HAM-D > 1 2 .
19. Probable schizophrenia.
20. CVA, hypertensive, dementia. Hachinski > 3.
21. Dementia. CVA. Hachinski >  3.











Raw data listings for the mean score and SD for the variables MACQ, 
DISTRESS, BVRT, LOG MEM, WALT, MMSE, NARTIQ, and VOCABIQ in 
all non-demented subjects and all healthy subjects
MACQ
All non-demented subjects All healthy subjects
Age Mean SD Cases Mean SD Cases
50-54 25.7 2.5 13 25.4 2.1 11
55-59 21.2 4 .4 16 20.5 4.6 13
60-64 24.6 3.9 13 25.2 3.2 11
65-69 25.4 4.7 17 25.8 4.6 16
70-74 24.1 4.1 15 24.1 4.3 11
75-79 25.7 4.8 14 24.8 5.0 8
80-84 23.8 6.9 11 22.3 8.0 6
85-89 24.0 3.1 7 24.0 3.7 5
90-94 23.3 2.1 8 23.2 2.6 5
50-94 24.2 4.5 114 24.0 4.6 86
DISTRESS
All non-demented subjects All healthy subjects
Age Mean SD Cases Mean SDi Cases
50-54 2.2 1.2 13 1.9 0.9 11
55-59 1.4 0.8 16 1.2 0.4 13
60-64 1.7 0.9 13 1.7 1.0 11
65-69 1.5 0.9 17 1.6 0.9 16
70-74 1.4 0.8 15 1.3 0.5 11
75-79 1.9 1.1 14 1.8 1.2 8
80-84 2.5 1.4 11 2.0 1.0 6
85-89 1.4 0.8 7 1.4 0.9 5
90-94 1.5 0.5 8 1.4 0.5 5
50-94 1.7 1.0 114 1.6 0.8 86
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BVRT
All non-demented subjects All healthy subjects
Age Mean SD Cases Mean SD C
50-54 7.5 1.3 13 7.5 1.4 11
55-59 6.7 1.9 16 6.9 1.7 13
60-64 7.5 1.9 13 7.8 1.4 11
65-69 6.5 1.2 17 6.6 1.3 16
70-74 5.2 1.8 15 5.4 2.0 11
75-79 4.6 2.0 14 5.1 1.7 8
80-84 3.8 1.9 11 4.7 1.8 6
85-89 4.3 1.4 7 3.8 .8 5
90-94 2.1 1.7 8 3.0 1.4 5
50-94 5.6 2.3 114 6.1 2.0 86
LOG MEM
All non-demented subjects All healthy subjects
Age Mean SD Cases Mean SD C
50-54 7.3 2.9 13 6.9 2.8 11
55-59 7.5 1.9 16 7.3 1.7 13
60-64 8.8 2.7 13 9.6 2.1 11
65-69 6.4 2.7 17 6.5 2.7 16
70-74 6.9 2.9 15 7.3 3.1 11
75-79 5.9 3.0 14 6.2 2.5 8
80-84 4.3 2.0 11 4.9 2.2 6
85-89 4.9 3.6 7 3.9 1.9 5
90-94 4.2 2.2 8 4.3 2.9 5
50-94 6.5 2.9 114 6.7 2.8 86
WALT
All non-demented subjects All healthy subjects
Age Mean SD Cases Mean SD Cases
50-54 13.0 4 .4 13 12.2 4.0 11
55-59 13.9 3.1 16 13.8 3.1 13
60-64 14.7 4.5 13 15.9 3.8 11
65-69 12.6 3.5 17 12.4 3.6 16
70-74 12.6 3.9 15 13.5 4.0 11
75-79 10.6 4 .4 14 10.4 4.6 8
80-84 10.0 4.2 11 11.1 4.5 6
85-89 10.5 3.8 7 9.9 4.0 5
90-94 9.9 3.6 8 9.9 3.8 5
50-94 12.2 4.1 114 12.6 4.1 86
159
MMSE
All non-demented subjects All healthy subjects
Age Mean SD Cases Meari SD Ca
50-54 28.5 1.9 13 28.3 2.1 11
55-59 28.6 1.7 16 28.9 1.2 13
60-64 28.8 1.0 13 29.0 1.0 11
65-69 27.9 2.0 17 27.9 2.1 16
70-74 28.1 1.6 15 28.5 1.7 11
75-79 26.9 1.4 14 27.3 1.4 8
80-84 26.2 2.0 11 26.9 1.6 6
85-89 27.0 2.5 7 26.2 2.5 5
90-94 26.0 3.3 8 26.6 3.4 5
50-94 27.7 2.1 114 28.0 1.9 86
NARTIQ
All non-demented subjects All healthy subjects
Age Mean SD Cases Mean SD Cases
50-54 110.2 10.3 13 107.7 9.1 11
55-59 112.8 10.0 16 113.5 9.0 13
60-64 115.2 7.8 13 116.8 6.4 11
65-69 107.4 10.4 17 107.4 10.8 16
70-74 105.1 8.4 15 106.5 8.7 11
75-79 109.9 8.1 14 112.9 4.8 8
80-84 104.7 11.7 11 107.9 11.5 6
85-89 103.0 10.8 7 103.2 12.8 5
90-94 105.6 11.5 8 107.2 13.3 5
50-94 108.7 10.2 114 109.7 9.9 86
VOCABIQ
All non-demented subjects All healthy subjects
Age Mean SD Cases Mean
50-54 112.4 13.5 13 109.7
55-59 111.3 12.7 16 112.1
60-64 116.1 9.0 13 118.5
65-69 109.0 8.8 17 109.0
70-74 109.8 11.0 15 112.0
75-79 115.0 9.6 14 117.5
80-84 103.5 12.6 11 105.6
85-89 109.0 14.2 7 105.0
90-94 106.5 10.2 8 108.2
















Consent form for the self-referral memory clinic studies
The relationship between memory problems and mood in people 
attending memory clinics
Consent form
I agree to take part in the above study which will consist of 
completing a questionnaire to do with my memory and how I have been 
feeling in general recently. This will take in the order of ten minutes. My 
decision whether to participate or not will not affect my treatment today 
or in the future in any way. Information given will be considered 
confidential to the Research Institute. There will be no disclosure of my 
name in any reports produced as a result of this research.
Signed Participant
Investigator
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